Document and Entity Information Document - shares	6 Months Ended
Document and Entity Information Document - shares	Mar. 25, 2018	Apr. 23, 2018
Document Information [Line Items]
Entity Registrant Name	QUALCOMM INC/DE
Entity Registrant State of Incorporation	Delaware
Entity Address	5775 Morehouse Dr.
Entity City	San Diego
Entity State	California
Entity Zip Code	92121-1714
Entity Phone Number	(858) 587-1121
Entity Employer ID	953685934
Entity Central Index Key	0000804328
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Document Type	10-Q
Document Period End Date	Mar. 25, 2018
Document Fiscal Year Focus	2018
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		1,482,622,312
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 25, 2018	Sep. 24, 2017
Current assets:
Cash and cash equivalents	$ 37,946	$ 35,029
Marketable securities	1,625	2,279
Accounts receivable, net	3,535	3,632
Inventories	1,797	2,035
Other current assets	641	618
Total current assets	45,544	43,593
Marketable securities	35	1,270
Deferred tax assets	1,126	2,900
Property, plant and equipment, net	3,224	3,216
Goodwill	6,676	6,623
Other intangible assets, net	3,435	3,737
Other assets	4,086	4,147
Total assets	64,126	65,486
Current liabilities:
Trade accounts payable	1,454	1,971
Payroll and other benefits related liabilities	1,262	1,183
Unearned revenues	502	502
Short-term debt	3,733	2,495
Other current liabilities	5,709	4,756
Total current liabilities	12,660	10,907
Unearned revenues	1,803	2,003
Income taxes payable	3,277	0
Long-term debt	19,361	19,398
Other liabilities	3,206	2,432
Total liabilities	40,307	34,740
Commitments and contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; 8 shares authorized; none outstanding	0	0
Common stock and paid-in capital, $0.0001 par value; 6,000 shares authorized; 1,482 and 1,474 shares issued and outstanding, respectively	495	274
Retained earnings	22,779	30,088
Accumulated other comprehensive income	545	384
Total stockholders’ equity	23,819	30,746
Total liabilities and stockholders’ equity	$ 64,126	$ 65,486

CONDENSED CONSOLIDATED BALANCE SHEETS PARENTHETICALS - $ / shares	Mar. 25, 2018	Sep. 24, 2017
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	8,000,000	8,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	6,000,000,000	6,000,000,000
Common stock, shares issued	1,482,000,000	1,474,000,000
Common stock, shares outstanding	1,482,000,000	1,474,000,000

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Revenues:
Equipment and services	$ 3,936	$ 3,689	$ 8,639	$ 7,828
Licensing	1,325	1,327	2,690	3,187
Total revenues	5,261	5,016	11,329	11,015
Costs and expenses:
Cost of revenues	2,239	2,208	4,902	4,651
Research and development	1,402	1,386	2,822	2,697
Selling, general and administrative	869	615	1,641	1,206
Other (Note 2)	310	78	1,493	954
Total costs and expenses	4,820	4,287	10,858	9,508
Operating income	441	729	471	1,507
Interest expense	(179)	(107)	(350)	(197)
Investment and other income, net (Note 2)	96	235	211	417
Income before income taxes	358	857	332	1,727
Income tax benefit (expense) (Note 3)	5	(108)	(5,922)	(296)
Net income (loss)	$ 363	$ 749	$ (5,590)	$ 1,431
Basic earnings (loss) per share	$ 0.25	$ 0.51	$ (3.78)	$ 0.97
Diluted earnings (loss) per share	$ 0.24	$ 0.50	$ (3.78)	$ 0.96
Shares used in per share calculations:
Basic	1,482	1,477	1,479	1,478
Diluted	1,494	1,489	1,479	1,492
Dividends per share announced	$ 0.57	$ 0.53	$ 1.14	$ 1.06

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Net income (loss)	$ 363	$ 749	$ (5,590)	$ 1,431
Other comprehensive income (loss), net of income taxes:
Foreign currency translation gains (losses)	178	16	173	(10)
Noncredit other-than-temporary impairment losses related to certain available-for-sale debt securities and subsequent changes in fair value	0	0	0	6
Reclassification of net other-than-temporary losses on available-for-sale securities included in net income (loss)	0	2	1	81
Net unrealized (losses) gains on other available-for-sale securities	(5)	69	(1)	(141)
Reclassification of net realized gains on available-for-sale securities included in net income (loss)	(8)	(37)	(9)	(129)
Net unrealized losses on derivative instruments	(7)	(5)	(6)	(3)
Reclassification of net realized losses (gains) on derivative instruments included in net income (loss)	2	(2)	3	(2)
Total other comprehensive income (loss)	160	43	161	(198)
Comprehensive income (loss)	$ 523	$ 792	$ (5,429)	$ 1,233

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017
Operating Activities:
Net income (loss)	$ (5,590)	$ 1,431
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization expense	751	671
Income tax provision in excess of (less than) income tax payments (Note 3)	5,477	(230)
Interest expense in excess of interest payments	207	129
Non-cash portion of share-based compensation expense	470	485
Net realized gains on marketable securities and other investments	(73)	(236)
Indefinite and long-lived asset impairment charges	33	34
Impairment losses on marketable securities and other investments	20	148
Other items, net	46	(32)
Changes in assets and liabilities:
Accounts receivable, net	94	(1,691)
Inventories	243	(245)
Other assets	70	107
Trade accounts payable	(511)	(677)
Payroll, benefits and other liabilities	1,166	2,592
Unearned revenues	(125)	(80)
Net cash provided by operating activities	2,278	2,406
Investing Activities:
Capital expenditures	(411)	(251)
Purchases of available-for-sale marketable securities	(5,758)	(8,802)
Proceeds from sales and maturities of available-for-sale securities	7,659	13,146
Deposits of investments designated as collateral	0	(2,000)
Acquisitions and other investments, net of cash acquired	(170)	(1,382)
Proceeds from other investments	159	7
Other items, net	2	42
Net cash provided by investing activities	1,481	760
Financing Activities:
Proceeds from short-term debt	5,563	5,113
Repayment of short-term debt	(4,330)	(4,864)
Proceeds from issuance of common stock	335	290
Repurchases and retirements of common stock	(425)	(727)
Dividends paid	(1,689)	(1,567)
Payments of tax withholdings related to vesting of share-based awards	(196)	(175)
Payment of purchase consideration related to RF360 joint venture	(115)	0
Other items, net	(17)	(52)
Net cash used by financing activities	(874)	(1,982)
Effect of exchange rate changes on cash and cash equivalents	32	(6)
Net increase in cash and cash equivalents	2,917	1,178
Cash and cash equivalents at beginning of period	35,029	5,946
Cash and cash equivalents at end of period	$ 37,946	$ 7,124

Basis of Presentation (Notes)

6 Months Ended

Mar. 25, 2018

Basis of Presentation [Abstract]

Basis of Presentation

Financial Statement Preparation. These condensed consolidated financial statements have been prepared by QUALCOMM Incorporated (collectively with its subsidiaries, the Company or Qualcomm) in accordance with accounting principles generally accepted in the United States of America (GAAP) for interim financial information and the instructions to Rule 10-01 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. In the opinion of management, the interim financial information includes all normal recurring adjustments necessary for a fair statement of the results for the interim periods. These condensed consolidated financial statements are unaudited and should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended September 24, 2017. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year. The Company operates and reports using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three-month and six-month periods ended March 25, 2018 and March 26, 2017 included 13 weeks and 26 weeks, respectively.

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation.

Earnings (Loss) Per Common Share. Basic earnings (loss) per common share is computed by dividing net income (loss) attributable to Qualcomm by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income attributable to Qualcomm by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans, if any, and the weighted-average number of common shares outstanding during the reporting period. Due to the net loss for the six months ended March 25, 2018, all of the common share equivalents issuable under share-based compensation plans had an anti-dilutive effect and were therefore excluded from the computation of diluted loss per share. The following table provides information about the diluted earnings per share calculation (in millions):



	Three Months Ended		Six Months Ended
	March 25, 2018	March 26, 2017	March 25, 2018	March 26, 2017
Dilutive common share equivalents included in diluted shares	12.2	11.3	—	14.2
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period	0.1	10.8	44.9	5.4

Share-Based Compensation. Total share-based compensation expense, related to all of the Company’s share-based awards, was comprised as follows (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Cost of revenues	$	10		$	10		$	21		$	20
Research and development	151			155			307			308
Selling, general and administrative	61			81			142			157
Share-based compensation expense before income taxes	222			246			470			485
Related income tax benefit	(29		)	(36		)	(77		)	(84		)
	$	193		$	210		$	393		$	401

At March 25, 2018, total unrecognized compensation expense related to nonvested restricted stock units granted prior to that date was $1.3 billion, which is expected to be recognized over a weighted-average period of 1.9 years. At March 25, 2018, the Company had 28.4 million restricted stock units outstanding and 7.8 million stock options outstanding.

Recent Accounting Pronouncements.

Share-based Awards: In March 2016, the Financial Accounting Standards Board (FASB) issued new guidance that changed the accounting for share-based awards, including income taxes, classification of awards and classification in the statement of cash flows. The Company adopted the new guidance in the first quarter of fiscal 2018. In accordance with the new guidance, excess tax benefits or deficiencies associated with share-based awards are recognized through earnings when the awards vest or settle, rather than in stockholders’ equity. In the six months ended March 25, 2018, net excess tax benefits associated with share-based awards of $21 million were recognized in the Company’s income tax provision. In addition, cash flows related to excess tax benefits are presented as an operating activity and cash payments made on an employee’s behalf for withheld shares are presented as financing activities, with the prior periods adjusted accordingly. As a result of these changes, amounts for the six months ended March 26, 2017 have been adjusted as follows: net cash provided by operating activities increased by $212 million with a corresponding offset to net cash used in financing activities. The new guidance also impacts the Company’s earnings per share calculation as the estimate of dilutive common share equivalents under the treasury stock method no longer assumes that the estimated tax benefits realized when an award is settled are used to repurchase shares. There was no impact of this change on the Company’s calculation of earnings per share as a result of the net loss for the six months ended March 25, 2018. The Company elected to continue its practice of estimating forfeitures expected to occur in determining the amount of compensation cost to be recognized each period.

Revenue Recognition: In May 2014, the FASB issued new guidance related to revenue recognition, which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. The new guidance requires a company to recognize revenue as control of goods or services transfers to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. It defines a five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the current guidance. The Company will adopt the new guidance in the first quarter of fiscal 2019 using the modified retrospective approach, with the cumulative effect of applying the new guidance recognized as an adjustment to the opening retained earnings balance. Given the scope of work required to implement the recognition and disclosure requirements under the new guidance, the Company has made progress in the identification of changes to policy, processes, systems and controls, and the Company continues to assess data availability and presentation necessary to meet the additional disclosure requirements of the guidance in the notes to the consolidated financial statements.

The Company currently expects the adoption of this new guidance to most significantly impact its licensing business. Specifically, the Company expects a change in the timing of revenues recognized from sales-based royalties. The Company currently recognizes sales-based royalties as revenues in the period in which such royalties are reported by licensees, which is after the conclusion of the quarter in which the licensees’ sales occur and when all other revenue recognition criteria are met. Under the new guidance, the Company will be required to estimate and recognize sales-based royalties in the period in which the associated sales occur, resulting in an acceleration of revenue recognition compared to the current method. Upon adoption of the new guidance, licenses to use portions of the Company’s intellectual property portfolio will be considered one performance obligation, and license fees will be recognized as revenues on a straight-line basis over the term of the license agreement, which is similar to the recognition of license revenues under the current guidance. The Company currently accounts for customer incentive arrangements in its licensing and semiconductor businesses, including volume-related and other pricing rebates or cost reimbursements for marketing and other activities involving certain of the Company’s products and technologies, in part based on the maximum potential liability. Under the new guidance, the Company will estimate the amount of all customer incentives. The Company does not otherwise expect the adoption of the new guidance to have a material impact on its businesses.

Financial Assets: In January 2016, the FASB issued new guidance on classifying and measuring financial instruments, which requires that (i) all equity investments, other than equity-method investments, in unconsolidated entities generally be measured at fair value through earnings and (ii) when the fair value option has been elected for financial liabilities, changes in fair value due to instrument-specific credit risk be recognized separately in other comprehensive income. Additionally, it changes the disclosure requirements for financial instruments. The Company will adopt the new guidance in the first quarter of fiscal 2019 and is in the process of determining the effects the adoption will have on its consolidated financial statements.

In June 2016, the FASB issued new guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The new guidance will be effective for the Company starting in the first quarter of fiscal 2021. Early adoption is permitted starting in the first quarter of fiscal 2020. The Company is in the process of determining the effects the adoption will have on its consolidated financial statements and whether to adopt the new guidance early.

Leases: In February 2016, the FASB issued new guidance related to leases that outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize lease liabilities and corresponding right-of-use assets for all leases with lease terms of greater than 12 months. It also changes the definition of a lease and expands the disclosure requirements of lease arrangements. The Company will adopt the new guidance in the first quarter of fiscal 2020 and expects to use the modified retrospective approach, with the cumulative effect of applying the new guidance recognized as an adjustment to opening retained earnings in the year of adoption. The Company is in the process of determining the effects the adoption will have on its consolidated financial statements and whether to apply any of the optional practical expedients.

Hedge Instruments: In August 2017, the FASB issued new guidance that expands and refines hedge accounting for both financial and non-financial risks, aligns the recognition and presentation of the effects of hedging instruments and hedged items in the financial statements, and includes targeted improvements related to the assessment of hedge effectiveness. The new guidance also modifies disclosure requirements for hedging activities. The Company plans to adopt the new guidance in the first quarter of fiscal 2019 and does not expect the effects of the adoption to have a material impact on its consolidated financial statements.

Other: In August 2016, the FASB issued new guidance related to the classification of certain cash receipts and cash payments on the statement of cash flows. The Company will adopt the new guidance in the first quarter of fiscal 2019 and does not expect the effects of the adoption to have a material impact on its consolidated statements of cash flows.

In October 2016, the FASB issued new guidance that changes the accounting for income tax effects of intra-entity transfers of assets other than inventory. Under the new guidance, the selling (transferring) entity is required to recognize a current tax expense or benefit upon transfer of the asset. Similarly, the purchasing (receiving) entity is required to recognize a deferred tax asset or deferred tax liability, as well as the related deferred tax benefit or expense, upon receipt of the asset. The Company will adopt the new guidance in the first quarter of fiscal 2019 and is in the process of determining the effects the adoption will have on its consolidated financial statements.

Composition of Certain Financial Statement Items (Notes)

6 Months Ended

Mar. 25, 2018

Balance Sheet Related Disclosures [Abstract]

Composition of Certain Financial Statement Items



Inventories (in millions)
	March 25, 2018		September 24, 2017
Raw materials	$	93	$	103
Work-in-process	643		799
Finished goods	1,061		1,133
	$	1,797	$	2,035



Other Current Liabilities (in millions)
	March 25, 2018		September 24, 2017
Customer incentives and other customer-related liabilities	$	2,882	$	2,804
Accrual for EC fine (Note 6)	1,232		—
Income taxes payable	575		312
Accrual for TFTC fine (Note 6)	156		778
Other	864		862
	$	5,709	$	4,756

Other Income, Costs and Expenses. Other expenses in the three months ended March 25, 2018 consisted of $310 million in restructuring and restructuring-related charges related to the Company’s Cost Plan (Note 9). Other expenses in the six months ended March 25, 2018 also included a $1.2 billion charge related to the European Commission (EC) fine (Note 6).

Other expenses in the three months ended March 26, 2017 consisted of $53 million in foreign currency losses related to the fine imposed by the Korea Fair Trade Commission (KFTC), which was accrued in the first quarter of fiscal 2017, and $25 million in restructuring and restructuring-related charges related to the Company’s Strategic Realignment Plan. Other expenses in the six months ended March 26, 2017 consisted of a $921 million charge related to the KFTC fine, including related foreign currency losses, and $33 million in restructuring and restructuring-related charges related to the Company’s Strategic Realignment Plan.



Investment and Other Income, Net (in millions)
	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Interest and dividend income	$	154		$	153		$	280		$	320
Net realized gains on marketable securities	3			67			13			206
Net realized gains on other investments	47			21			60			30
Impairment losses on marketable securities	—			(3		)	(1		)	(125		)
Impairment losses on other investments	(11		)	(2		)	(19		)	(23		)
Net gains on derivative investments	10			13			9			20
Equity in net losses of investees	(17		)	(14		)	(38		)	(11		)
Net losses on foreign currency transactions	(90		)	—			(93		)	—
	$	96		$	235		$	211		$	417

Income Taxes (Notes)	6 Months Ended
Income Taxes (Notes)	Mar. 25, 2018
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes On December 22, 2017, tax reform legislation known as the Tax Cuts and Jobs Act (the Tax Legislation) was enacted in the United States (U.S.). The Tax Legislation significantly revises the U.S. corporate income tax by, among other things, lowering the corporate income tax rate to 21%, implementing a modified territorial tax system and imposing a one-time repatriation tax on deemed repatriated earnings and profits of U.S.-owned foreign subsidiaries (the Toll Charge). As a fiscal-year taxpayer, certain provisions of the Tax Legislation impacted the Company in fiscal 2018, including the change in the corporate income tax rate and the Toll Charge, while other provisions will be effective starting at the beginning of fiscal 2019, including the implementation of a modified territorial tax system. The U.S. federal income tax rate reduction was effective as of January 1, 2018. Accordingly, the Company’s federal statutory income tax rate for fiscal 2018 reflects a blended rate of approximately 25%. Pursuant to the Securities and Exchange Commission Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (SAB 118), given the amount and complexity of the changes in tax law resulting from the Tax Legislation, the Company has not finalized the accounting for the income tax effects of the Tax Legislation. This includes the provisional amounts recorded related to the Toll Charge, the remeasurement of deferred taxes and the change in the Company’s indefinite reinvestment assertion. Further, the Company is in the process of analyzing the effects of new taxes due on certain foreign income, such as GILTI (global intangible low-taxed income), BEAT (base-erosion anti-abuse tax) and FDII (foreign-derived intangible income), and limitations on interest expense deductions (if certain conditions apply), all of which are effective starting in fiscal 2019, as well as other provisions of the Tax Legislation. The Company has elected to account for GILTI as period costs if and when incurred. As a result of recognizing the impact of the Tax Legislation in income tax expense (benefit), certain tax effects, which were nominal, were stranded in accumulated other comprehensive income, and the Company will not reclassify such amounts to retained earnings. The impact of the Tax Legislation may differ from this estimate, possibly materially, during the one-year measurement period due to, among other things, further refinement of the Company’s calculations, changes in interpretations and assumptions the Company has made, guidance that may be issued and actions the Company may take as a result of the Tax Legislation. The Company has preliminarily accounted for the effects of the Tax Legislation, which resulted in a charge of $5.87 billion to income tax expense recorded discretely in the first quarter of fiscal 2018, comprised of $5.3 billion related to the estimated Toll Charge and $562 million resulting from the estimated impact of remeasurement of U.S. deferred tax assets and liabilities that existed at the end of fiscal 2017 at a lower enacted corporate income tax rate. The Company recorded a $15 million net tax benefit discretely in the second quarter of fiscal 2018 related to refining estimates associated with the Toll Charge and impact of remeasurement of U.S. deferred tax assets and liabilities. The Toll Charge is based on the Company’s post-1986 earnings and profits of U.S.-owned foreign subsidiaries through December 31, 2017 for which the Company had previously deferred U.S. income taxes. The total estimated Toll Charge of $5.3 billion was recorded discretely in the first six months of fiscal 2018. The Company has not yet finalized its calculation of the total post-1986 foreign earnings and profits for the respective foreign subsidiaries. Further, the Toll Charge is based in part on the amount of those earnings held in cash and other specific assets. The Company remeasured its deferred tax assets and liabilities that existed at the end of fiscal 2017 based on the income tax rate at which they are expected to reverse, which primarily assumes the reduced income tax rate of 21% applicable in fiscal 2019, resulting in a reduction to noncurrent deferred tax assets of $540 million in the first six months of fiscal 2018. As of December 24, 2017, the Company no longer considers available cash balances that existed at the end of fiscal 2017 related to undistributed pre-fiscal 2018 earnings and profits of certain U.S.-owned foreign subsidiaries to be indefinitely reinvested and recorded a tax expense of $93 million related to foreign withholding taxes during the first six months of fiscal 2018, of which $86 million was recorded discretely in the first quarter of fiscal 2018. The Company otherwise continues to consider other undistributed earnings of certain U.S.-owned foreign subsidiaries to be indefinitely reinvested based on its current plans for use and/or investment outside of the U.S., and therefore, no liability has been recorded for such taxes. However, as a result of the Tax Legislation, the Company is reassessing its intentions related to its indefinite reinvestment assertion. Should the Company decide to no longer indefinitely reinvest such earnings outside the U.S., the Company would have to adjust the income tax provision in the period such determination is made. As a result of the Toll Charge imposed by the Tax Legislation, the Company expects to fully utilize all of its unused federal tax credits that existed at the end of fiscal 2017 of $1.1 billion, which resulted in a reduction to noncurrent deferred tax assets in the first quarter of fiscal 2018, and the federal tax credits that are expected to be generated in fiscal 2018. The Company will elect to pay the Toll Charge, interest free, over a period of eight years, with payments beginning on January 15, 2019. The Company did not discount the amount of the Toll Charge. The cash amount the Company currently estimates will be paid for the Toll Charge, net of tax credit carryforwards and expected tax credits estimated to be generated in fiscal 2018, is $3.2 billion. The estimated first installment of $251 million is due on January 15, 2019 and was included in other current liabilities. The remaining liability was included in noncurrent income taxes payable. The Company estimates its annual effective income tax rate to be approximately 438% for fiscal 2018, as compared to the 18% effective income tax rate for fiscal 2017, primarily as a result of the estimated charge of $5.95 billion recorded to income tax expense in the first six months of fiscal 2018 related to the combined effect of the Toll Charge, the remeasurement of deferred tax assets and liabilities and the Company’s decision to no longer indefinitely reinvest certain foreign earnings, all of which resulted from the Tax Legislation. The estimated annual effective tax rate for fiscal 2018 was also impacted by the EC fine (Note 6) recorded in the first quarter of fiscal 2018, which is not deductible for tax purposes and is attributable to a foreign jurisdiction. Tax benefits from foreign income taxed at rates lower than rates in the U.S. are expected to be approximately 31% in fiscal 2018, compared to 32% in fiscal 2017, primarily due to the lower U.S. federal statutory income tax rate enacted by the Tax Legislation, partially offset by lower estimated U.S. revenues primarily related to decreased royalty revenues from Apple’s contract manufacturers and the other licensee in dispute. The estimated annual effective tax rate for fiscal 2018 also reflects a blended U.S. federal statutory income tax rate of 25% as a result of the Tax Legislation and the increase in the Company’s Singapore tax rate due to the expiration of certain of its tax incentives in March 2017. The annual effective tax rate of 18% for fiscal 2017 reflected the KFTC and TFTC fines (Note 6), which were not deductible for tax purposes and were each attributable to the U.S. and foreign jurisdictions. The effective tax rate of 1% benefit for the second quarter of fiscal 2018 was lower than the estimated annual effective tax rate primarily due to the estimated charge of $5.96 billion recorded discretely to income tax expense in the first quarter of fiscal 2018 related to the effects of certain components of the Tax Legislation and the EC fine recorded in the first quarter of fiscal 2018, as well as the $15 million tax benefit recorded discretely in the second quarter of fiscal 2018 related to refining estimates associated with the Tax Legislation. Unrecognized tax benefits were $347 million and $372 million at March 25, 2018 and September 24, 2017, respectively. The Company believes that it is reasonably possible that the total amounts of unrecognized tax benefits at March 25, 2018 may increase or decrease in the next 12 months. The Company is subject to income taxes in the U.S. and numerous foreign jurisdictions, and is currently under examination by various tax authorities worldwide, most notably in countries where the Company earns a routine return and tax authorities believe substantial value-add activities are performed. These examinations are at various stages with respect to assessments, claims, deficiencies and refunds, many of which are open for periods after fiscal 2000. The Company continually assesses the likelihood and amount of potential adjustments and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts give rise to a revision become known. As of March 25, 2018, the Company believes that adequate amounts have been reserved for based on facts known. However, the final determination of tax audits and any related legal proceedings could materially differ from amounts reflected in the Company’s income tax provision and the related accruals.

Stockholders' Equity (Notes)

6 Months Ended

Mar. 25, 2018

Stockholders' Equity Attributable to Parent [Abstract]

Stockholders' Equity

Stockholders’ Equity

Changes in stockholders’ equity in the six months ended March 25, 2018 were as follows (in millions):



	Total Stockholders’ Equity
Balance at September 24, 2017	$	30,746
Net loss	(5,590		)
Other comprehensive income	161
Common stock issued under employee benefit plans and related tax benefits	343
Share-based compensation	499
Tax withholdings related to vesting of share-based payments	(196		)
Dividends	(1,719		)
Stock repurchases	(425		)
Balance at March 25, 2018	$	23,819

Accumulated Other Comprehensive Income. Changes in the components of accumulated other comprehensive income, net of income taxes, in stockholders’ equity in the six months ended March 25, 2018 were as follows (in millions):



	Foreign Currency Translation Adjustment		Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities		Net Unrealized Gain (Loss) on Other Available-for-Sale Securities			Net Unrealized (Loss) Gain on Derivative Instruments			Other Gains		Total Accumulated Other Comprehensive Income
Balance at September 24, 2017	$	147	$	23	$	218		$	(8	)	$	4	$	384
Other comprehensive income (loss) before reclassifications	173		—		(1		)	(6		)	—		166
Reclassifications from accumulated other comprehensive income	—		1		(9		)	3			—		(5		)
Other comprehensive income (loss)	173		1		(10		)	(3		)	—		161
Balance at March 25, 2018	$	320	$	24	$	208		$	(11	)	$	4	$	545

Reclassifications from accumulated other comprehensive income related to available-for-sale securities were negligible in both the three and six months ended March 25, 2018 and $35 million and $48 million in the three and six months ended March 26, 2017, respectively, and were recorded in investment and other income, net (Note 2).

Stock Repurchase Program. On March 9, 2015, the Company announced a stock repurchase program authorizing it to repurchase up to $15 billion of the Company’s common stock. The stock repurchase program has no expiration date. In the six months ended March 25, 2018 and March 26, 2017, the Company repurchased and retired 6.8 million and 11.5 million shares for $425 million and $727 million, respectively, before commissions. At March 25, 2018, $1.2 billion remained authorized for repurchase under the Company’s stock repurchase program.

Dividends. On March 8, 2018, the Company announced a 9% increase in its quarterly dividend per share of common stock from $0.57 to $0.62, which is effective for dividends payable after March 21, 2018. On April 17, 2018, the Company announced a cash dividend of $0.62 per share on the Company’s common stock, payable on June 20, 2018 to stockholders of record as of the close of business on May 30, 2018. In the six months ended March 25, 2018 and March 26, 2017, dividends charged to retained earnings were as follows (in millions, except per share data):



	2018				2017
	Per Share		Total		Per Share		Total
First quarter	$	0.57	$	862	$	0.53	$	801
Second quarter	0.57		857		0.53		798
	$	1.14	$	1,719	$	1.06	$	1,599

Employee Benefit Plans. On March 23, 2018, the Company’s stockholders approved an amendment to the Amended and Restated QUALCOMM Incorporated 2001 Employee Stock Purchase Plan to increase the share reserve by 30,000,000 shares to approximately 101,709,000.

Debt (Notes)

6 Months Ended

Mar. 25, 2018

Debt Disclosure [Abstract]

Debt

Revolving Credit Facilities. The Company has an Amended and Restated Revolving Credit Facility (2016 Amended and Restated Revolving Credit Facility) that provides for unsecured revolving facility loans, swing line loans and letters of credit in an aggregate amount of up to $5.0 billion, of which $530 million and $4.47 billion will expire in February 2020 and November 2021, respectively. Proceeds from the 2016 Amended and Restated Revolving Credit Facility are expected to be used for general corporate purposes. At March 25, 2018 and September 24, 2017, the Company had not borrowed any funds under the 2016 Amended and Restated Revolving Credit Facility.

In March 2018, the Company entered into a credit agreement, which was amended on April 20, 2018 in connection with Amendment No. 2 to the NXP purchase agreement (Amendment No. 2) (Note 8), that provides for senior unsecured delayed-draw revolving facility loans in an aggregate amount of $3.0 billion (as amended, the 2018 Revolving Credit Facility). Proceeds from the 2018 Revolving Credit Facility, if drawn, will be used in part to finance the proposed acquisition of NXP (Note 8) and for general corporate purposes. Commitments under the 2018 Revolving Credit Facility will expire on the first to occur of (i) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP, (ii) if the closing date under the 2018 Revolving Credit Facility has not occurred, the date that is five business days following July 25, 2018 and (iii) the termination of the commitments in accordance with the provisions of the 2018 Revolving Credit Facility providing for voluntary and mandatory commitment reductions. Loans under the 2018 Revolving Credit Facility will mature on December 31, 2018 and will bear interest, at the option of the Company, at either the reserve-adjusted Eurocurrency Rate (determined in accordance with the 2018 Revolving Credit Facility) or the Base Rate (determined in accordance with the 2018 Revolving Credit Facility), in each case plus an applicable margin based on the Company’s long-term unsecured senior, non-credit enhanced debt ratings. The initial margins over the reserve-adjusted Eurocurrency Rate and the Base Rate based on Qualcomm’s debt ratings as of March 25, 2018 will be 0.75% and 0.00% per annum, respectively. The 2018 Revolving Credit Facility has a ticking fee, which is based on Qualcomm’s debt ratings and initially accrues at a rate of 0.05% per annum commencing on March 6, 2018. At March 25, 2018, the Company had not borrowed any funds under the 2018 Revolving Credit Facility.

Commercial Paper Program. The Company has an unsecured commercial paper program, which provides for the issuance of up to $5.0 billion of commercial paper. Net proceeds from this program are used for general corporate purposes. Maturities of commercial paper can range from 1 day to up to 397 days. At March 25, 2018 and September 24, 2017, the Company had $2.2 billion and $999 million, respectively, of outstanding commercial paper included in short-term debt with a weighted-average interest rate of 1.98% and 1.19%, respectively, which included fees paid to the commercial paper dealers, and weighted-average remaining days to maturity of 44 days and 45 days, respectively. The carrying value of the outstanding commercial paper approximated its estimated fair value at March 25, 2018 and September 24, 2017.

Term Loan Facilities. The Company is party to a credit agreement, which was amended on April 20, 2018, in connection with Amendment No. 2, that provides for senior unsecured delayed-draw term facility loans in an aggregate amount of $4.0 billion (as amended, the 2016 Term Loan Facility). Proceeds from the 2016 Term Loan Facility, if drawn, will be used to finance the proposed acquisition of NXP. Commitments under the 2016 Term Loan Facility will expire on the first to occur of (i) the consummation of the proposed acquisition of NXP without using loans under the 2016 Term Loan Facility, (ii) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP and (iii) the date that is five business days following July 25, 2018. At March 25, 2018 and September 24, 2017, the Company had not borrowed any funds under the 2016 Term Loan Facility.

In March 2018, the Company entered into a credit agreement, which was amended on April 20, 2018 in connection with Amendment No. 2, that provides for senior unsecured delayed-draw term facility loans in an aggregate amount of $3.0 billion (as amended, the 2018 Term Loan Facility). Proceeds from the 2018 Term Loan Facility, if drawn, will be used in part to finance the proposed acquisition of NXP and for general corporate purposes. Commitments under the 2018 Term Loan Facility will expire on the first to occur of (i) the consummation of the proposed acquisition of NXP without using loans under the 2018 Term Loan Facility, (ii) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP, (iii) the date that is five business days following July 25, 2018 and (iv) the termination of the commitments in accordance with the provisions of the 2018 Term Loan Facility providing for voluntary and mandatory commitment reductions. Loans under the 2018 Term Loan Facility will mature on December 31, 2018 and will bear interest, at the option of the Company, at either the reserve-adjusted Eurocurrency Rate (determined in accordance with the 2018 Term Loan Facility) or the Base Rate (determined in accordance with the 2018 Term Loan Facility), in each case plus an applicable margin based on the Company’s long-term unsecured senior, non-credit enhanced debt ratings. The initial margins over the reserve-adjusted Eurocurrency Rate and the Base Rate based on Qualcomm’s debt ratings as of March 25, 2018 will be 0.875% and 0.00% per annum, respectively. The 2018 Term Loan Facility has a ticking fee, which is based on Qualcomm’s debt ratings and initially accrues at a rate of 0.05% per annum commencing on March 6, 2018. At March 25, 2018, the Company had not borrowed any funds under the 2018 Term Loan Facility.

Long-term Debt. The following table provides a summary of the Company’s long-term debt (in millions, except percentages):



		March 25, 2018				September 24, 2017
		Amount			Effective Rate	Amount			Effective Rate
May 2015 Notes
	Floating-rate three-month LIBOR plus 0.27% notes due May 18, 2018	$	250		2.21%	$	250		1.65%
	Floating-rate three-month LIBOR plus 0.55% notes due May 20, 2020	250			2.49%	250			1.92%
	Fixed-rate 1.40% notes due May 18, 2018	1,250			2.94%	1,250			1.93%
	Fixed-rate 2.25% notes due May 20, 2020	1,750			2.79%	1,750			2.20%
	Fixed-rate 3.00% notes due May 20, 2022	2,000			3.34%	2,000			2.65%
	Fixed-rate 3.45% notes due May 20, 2025	2,000			3.46%	2,000			3.46%
	Fixed-rate 4.65% notes due May 20, 2035	1,000			4.74%	1,000			4.74%
	Fixed-rate 4.80% notes due May 20, 2045	1,500			4.71%	1,500			4.71%
May 2017 Notes
	Floating-rate three-month LIBOR plus 0.36% notes due May 20, 2019	750			2.37%	750			1.80%
	Floating-rate three-month LIBOR plus 0.45% notes due May 20, 2020	500			2.43%	500			1.86%
	Floating-rate three-month LIBOR plus 0.73% notes due January 30, 2023	500			2.56%	500			2.11%
	Fixed-rate 1.85% notes due May 20, 2019	1,250			2.00%	1,250			2.00%
	Fixed-rate 2.10% notes due May 20, 2020	1,500			2.19%	1,500			2.19%
	Fixed-rate 2.60% notes due January 30, 2023	1,500			2.70%	1,500			2.70%
	Fixed-rate 2.90% notes due May 20, 2024	1,500			3.01%	1,500			3.01%
	Fixed-rate 3.25% notes due May 20, 2027	2,000			3.46%	2,000			3.46%
	Fixed-rate 4.30% notes due May 20, 2047	1,500			4.47%	1,500			4.47%
Total principal		21,000				21,000
	Unamortized discount, including debt issuance costs	(97		)		(106		)
	Hedge accounting fair value adjustments	(43		)		—
	Total	$	20,860			$	20,894
Reported as:
	Short-term debt	$	1,499			$	1,496
	Long-term debt	19,361				19,398
	Total	$	20,860			$	20,894

The Company’s 2019 floating-rate notes, 2020 floating-rate notes, 2019 fixed-rate notes and 2020 fixed-rate notes issued in May 2017 for an aggregate principal amount of $4.0 billion are subject to a special mandatory redemption at a price equal to 101% of the aggregate principal amount, plus accrued and unpaid interest to, but excluding, the date of such mandatory redemption. The redemption is required on the first to occur of (i) the termination of the NXP purchase agreement or (ii) if the NXP transaction has not closed, by June 1, 2018. The Company may redeem the fixed-rate notes at any time in whole, or from time to time in part, at specified make-whole premiums as defined in the applicable form of note. The Company may not redeem the other floating-rate notes prior to maturity. The obligations under the notes rank equally in right of payment with all of the Company’s other senior unsecured indebtedness and will effectively rank junior to all liabilities of the Company’s subsidiaries. At March 25, 2018 and September 24, 2017, the aggregate fair value of the notes, based on Level 2 inputs, was approximately $20.5 billion and $21.5 billion, respectively.

In connection with issuance of the May 2015 Notes, the Company entered into interest rate swaps with an aggregate notional amount of $3.0 billion, which effectively converted all of the fixed-rate notes due in 2018 and approximately 43% and 50% of the fixed-rate notes due in 2020 and 2022, respectively, into floating-rate notes. The net gains and losses on the interest rate swaps, as well as the offsetting gains or losses on the related fixed-rate notes attributable to the hedged risks, are recorded in earnings in interest expense in the current period. The Company did not enter into similar interest rate swaps in connection with issuance of the May 2017 Notes.

The effective interest rates for the notes include the interest on the notes, amortization of the discount, which includes debt issuance costs, and if applicable, adjustments related to hedging. Interest is payable in arrears quarterly for the floating-rate notes and semi-annually for the fixed-rate notes. Cash interest paid related to the Company’s commercial paper program and long-term debt, net of cash received from the related interest rate swaps, was $317 million and $150 million in the six months ended March 25, 2018 and March 26, 2017, respectively.

Debt Covenants. The 2016 Amended and Restated Revolving Credit Facility, the 2016 Term Loan Facility, the 2018 Revolving Credit Facility and the 2018 Term Loan Facility require that the Company comply with certain covenants, including one financial covenant to maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in each of the respective agreements, of not less than three to one at the end of each fiscal quarter. The Company is not subject to any financial covenants under the notes nor any covenants that would prohibit the Company from incurring additional indebtedness ranking equal to the notes, paying dividends, issuing securities or repurchasing securities issued by it or its subsidiaries. At March 25, 2018 and September 24, 2017, the Company was in compliance with the applicable covenants under each facility outstanding at such time.

Commitments and Contingencies (Notes)

6 Months Ended

Mar. 25, 2018

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Legal and Regulatory Proceedings.

ParkerVision, Inc. v. QUALCOMM Incorporated: On May 1, 2014, ParkerVision filed a complaint against the Company in the United States District Court for the Middle District of Florida alleging that certain of the Company’s products infringe certain ParkerVision patents. On August 21, 2014, ParkerVision amended the complaint, now captioned ParkerVision, Inc. v. QUALCOMM Incorporated, Qualcomm Atheros, Inc., HTC Corporation, HTC America, Inc., Samsung Electronics Co., LTD., Samsung Electronics America, Inc. and Samsung Telecommunications America, LLC, broadening the allegations. ParkerVision alleged that the Company infringes 11 ParkerVision patents and seeks damages and injunctive and other relief. On December 3, 2015, ParkerVision dismissed six patents from the lawsuit and granted the Company and all other defendants a covenant not to assert those patents against any existing products. On February 2, 2016, after agreement among the parties, the District Court stayed the remainder of the case pending the resolution of the complaint filed by ParkerVision against the Company and other parties with the United States International Trade Commission (ITC) described below. Subsequently, ParkerVision announced that it had reached a settlement with Samsung which dismissed the Samsung entities from the District Court case. The Company had previously filed Inter-Partes Review petitions with the United States Patent and Trademark Office (USPTO) to invalidate all asserted claims of several of the remaining patents. On March 7, 2017, the USPTO decided in the Company’s favor with respect to all asserted claims of one such patent. After the ITC action described below was closed, and upon agreement among the parties, on May 24, 2017, the District Court further stayed the District Court case pending ParkerVision’s appeal of the USPTO’s invalidation decisions.

On December 14, 2015, ParkerVision filed another complaint against the Company in the United States District Court for the Middle District of Florida alleging patent infringement. Apple Inc., Samsung Electronics Co., LTD., Samsung Electronics America, Inc., Samsung Telecommunications America, LLC, Samsung Semiconductor, Inc., LG Electronics, Inc., LG Electronics U.S.A., Inc. and LG Electronics MobileComm U.S.A., Inc. are also named defendants. The complaint asserts that certain of the Company’s products infringe four additional ParkerVision patents and seeks damages and other relief. On December 15, 2015, ParkerVision filed a complaint with the ITC pursuant to Section 337 of the Tariff Act of 1930 against the same parties asserting the same four patents. The complaint seeks an exclusion order barring the importation of products that use either of two Company transceivers or one Samsung transceiver and a cease and desist order preventing the Company and the other defendants from carrying out commercial activities within the United States related to such products. On January 13, 2016, the Company served its answer to the District Court complaint. On January 15, 2016, the ITC instituted an investigation. On February 12, 2016, the District Court case was stayed pending completion of the ITC investigation. Subsequently, ParkerVision announced that it had reached a settlement with Samsung which dismissed the Samsung entities from the ITC investigation and related District Court case. On February 2, 2017, the ITC granted ParkerVision’s motion to drop all but one patent and one accused product from the ITC investigation. On March 12, 2017, one day before the ITC hearing was scheduled to begin, ParkerVision moved to withdraw its ITC complaint in its entirety. The Company and the other defendants did not oppose the withdrawal of the complaint. On April 28, 2017, the ITC formally closed the investigation. On May 4, 2017, ParkerVision filed a motion to reopen the related District Court Case, and on May 26, 2017, the District Court granted the motion. On March 16, 2018, the parties agreed to dismiss three of ParkerVision’s patents from the case without prejudice, leaving only one patent at issue. No trial date has been set.

Apple Inc. (Apple) v. QUALCOMM Incorporated: On January 20, 2017, Apple filed a complaint against the Company in the United States District Court for the Southern District of California seeking declarations with respect to several of the Company’s patents and alleging that the Company breached certain agreements and violated federal antitrust and California state unfair competition laws. In its initial complaint, Apple sought declaratory judgments of non-infringement by Apple of nine of the Company’s patents, or in the alternative, a declaration of royalties Apple must pay for the patents. Apple further sought a declaration that the Company’s sale of baseband chipsets exhausts the Company’s patent rights for patents embodied in those chipsets. Separately, Apple sought to enjoin the Company from seeking excessive royalties from Apple and to disgorge royalties paid by Apple’s contract manufacturers that the court finds were not fair, reasonable and non-discriminatory (FRAND). Apple also claimed that the Company’s refusal to make certain payments to Apple under a Business Cooperation and Patent Agreement (Cooperation Agreement) constitutes a breach of contract in violation of California law and sought damages in the amount of the unpaid payments, alleged to be approximately $1 billion. In addition, Apple claimed that the Company has refused to deal with competitors in contravention of the Company’s agreements with applicable standard setting organizations, has used its market position to impose contractual obligations on Apple that prevented Apple from challenging the Company’s licensing practices, has tied the purchase of the Company’s CDMA-enabled and “premium” LTE-enabled chipsets to licensing certain of the Company’s patents and has required Apple to purchase baseband chipsets exclusively from the Company as a condition of the Company’s payment to Apple of certain rebates, in violation of Section 2 of the Sherman Act and the California Unfair Competition Law. Apple sought injunctive relief with respect to these claims and a judgment awarding its expenses, costs and attorneys’ fees.

On April 10, 2017, the Company filed its Answer and Counterclaims (amended on May 24, 2017) in response to Apple’s complaint denying Apple’s claims and asserting claims against Apple. The counterclaims against Apple include tortious interference with the Company’s long-standing Subscriber Unit License Agreements (SULAs) with third-party contract manufacturers of Apple devices, causing those contract manufacturers to withhold certain royalty payments owed to the Company and violate their audit obligations; breach of contract and the implied covenant of good faith and fair dealing relating to the parties’ Cooperation Agreement; unjust enrichment and declaratory relief relating to the Cooperation Agreement; breach of contract based on Apple’s failure to pay amounts owed to the Company under a Statement of Work relating to a high-speed feature of the Company’s chipsets; breach of the parties’ software agreement; and violation of California Unfair Competition Law based on Apple’s threatening the Company to prevent it from promoting the superior performance of the Company’s own chipsets. The Company also seeks declaratory judgments that the Company has satisfied its FRAND commitments with respect to Apple, and that the Company’s SULAs with the contract manufacturers do not violate either competition law or the Company’s FRAND commitments. On June 19, 2017, Apple filed a Partial Motion to Dismiss the Company’s counterclaim for violation of the California Unfair Competition Law. The court granted that motion on November 8, 2017. On June 20, 2017, Apple filed an Answer and Affirmative Defenses to the rest of the Company’s counterclaims, and also filed an Amended Complaint reiterating all of the original claims and adding claims for declaratory judgments of invalidity of the nine patents that are subject to declaratory judgment claims in the original complaint, adding new declaratory judgment claims for non-infringement, invalidity and a declaration of royalties for nine more patents. Apple also added claims for declaratory judgments that certain of the Company’s agreements are unenforceable. On July 21, 2017, the Company filed an Answer to Apple’s Amended Complaint as well as a motion to dismiss the new declaratory judgment claims for non-infringement, invalidity and a declaration of royalties for the nine additional patents. The court granted the Company’s motion on November 8, 2017. On July 18, 2017, Apple filed a motion to consolidate this action with QUALCOMM Incorporated v. Compal Electronics, Inc., et al., discussed below, and on September 13, 2017, the court granted that motion. Fact discovery is set to close in these cases on May 11, 2018. A final pretrial conference is scheduled for September 28, 2018. The trials have not been scheduled.

On January 23, 2017, an Apple subsidiary in China filed two complaints against the Company in the Beijing Intellectual Property Court. On March 31, 2017, the court granted an application by Apple Inc. to join the actions as a plaintiff, and Apple amended the complaints. One of the complaints alleges a violation of China’s Anti-Monopoly Law (AML complaint); the other complaint requests a determination of the terms of a patent license between the Company and Apple (FRAND complaint). The AML complaint alleges that (i) the Company has abused its dominant position in communication standard-essential patents licensing markets and certain global baseband chipset markets by charging and offering royalty terms that were excessively high; (ii) the Company refused to license certain implementers of standardized technologies, including Apple and baseband chipset manufacturers; (iii) the Company forced Apple to use only the Company’s products and services; and (iv) the Company bundled licenses to standard-essential patents with licenses to non-standard-essential patents and imposed other unreasonable or discriminatory trading terms on Apple in violation of the AML. The AML complaint seeks a decree that the Company cease the alleged abuse of dominance, as well as damages in the amount of 1 billion Chinese Renminbi (approximately $158 million based on the exchange rate on March 25, 2018). The FRAND complaint makes allegations similar to the AML complaint and further alleges that the Company refused to offer licensing terms for the Company’s cellular standard-essential patents consistent with the Company’s FRAND licensing commitments and failed to provide to Apple certain information about the Company’s patents. The FRAND complaint seeks (i) a declaration that the license terms offered to Apple by the Company for its mobile communication standard essential patents are not compliant with FRAND; (ii) an order that the Company cease its actions that allegedly violate the Company’s FRAND obligations, including pricing on unfair, unreasonable and excessive terms, refusing to deal, imposing unreasonable trade conditions and failing to provide information on the Company’s patents; and (iii) a determination of FRAND-compliant license terms for the Company’s Chinese standard-essential patents. Apple also seeks its expenses in each of the cases. On August 3, 2017, the Company received three additional complaints filed by an Apple subsidiary and Apple Inc. against the Company in the Beijing Intellectual Property Court. The complaints seek declaratory judgments of non-infringement of three Qualcomm patents. The Company has filed jurisdictional and other objections to the complaints.

On February 16, 2017, Apple and one of its Japanese subsidiaries filed four complaints against the Company in the Tokyo District Court. In three of the complaints, Apple seeks declaratory judgment of non-infringement by Apple of three of the Company’s patents. Apple further seeks a declaration that the Company’s patent rights with respect to those three patents are exhausted by the Company’s SULAs with the contract manufacturers of Apple’s devices as well as the Company’s sale of baseband chipsets. Apple also seeks an award of fees. On January 30, 2018, the court dismissed one of the complaints, finding that Apple lacked standing based on the facts it alleged in that complaint. The court has yet to rule on whether Apple has standing in the remaining complaints. On May 15, 2017, the Company learned of the fourth complaint. In that complaint, Apple and one of its Japanese subsidiaries seek damages of 100 million Japanese Yen (approximately $1 million based on the exchange rate on March 25, 2018) from the Company, based on allegations that the Company violated the Japanese Antimonopoly Act and the Japanese Civil Code. In particular, the fourth complaint alleges that (i) the Company holds a monopoly position in the market for baseband processor chipsets that implement certain cellular standards; (ii) the Company collects double royalties through its license agreements and the sale of chipsets; (iii) the Company refused to grant Apple a license on FRAND terms and forced Apple to execute a rebate agreement under unreasonable conditions; (iv) the Company refused to grant Apple a direct license; and (v) the Company demanded a license fee based on the market value of the total device. The Company has filed jurisdictional and other objections to all four of the complaints.

On March 2, 2017, the Company learned that Apple and certain of its European subsidiaries issued a Claim Form against the Company in the UK High Court of Justice, Chancery Division, Patents Court on January 23, 2017. Apple subsequently filed an Amended Claim Form and Particulars of Claim. Both the Amended Claim Form and the Particulars of Claim allege several European competition law claims, including refusal to license competing chipmakers, failure to offer Apple a direct license to the Company’s standard-essential patents on FRAND terms, demanding excessive royalties for the Company’s standard-essential patents, and demanding excessive license fees for the use of the Company’s standard-essential patents in connection with chipsets purchased from the Company. Apple also seeks declarations that the Company is obliged to offer a direct patent license to Apple in respect of standard-essential patents actually practiced on fair, reasonable and non-discriminatory terms and that using the Company’s chipsets does not infringe any of the Company’s patents because the Company exhausted its patent rights. Finally, Apple seeks declarations that five of the Company’s European (UK) patents are invalid and not essential, and an order that each of those patents be revoked.

On April 18, 2017, Apple and one of its Taiwanese subsidiaries filed a complaint against the Company in the Taiwan Intellectual Property Court alleging that the Company has abused a dominant market position in licensing wireless standard-essential patents and selling baseband chipsets, including improper pricing, refusal to deal, exclusive dealing, tying, imposing unreasonable trade terms and discriminatory treatment. The complaint seeks rulings that the Company not use the sales price of the terminal device as the royalty base for standard-essential patents; not leverage its cellular standard-essential patents to obtain licenses of its non-standard-essential patents or demand cross-licenses without proper compensation; not refuse, reduce, delay or take any other action to limit the supply of its baseband chipsets to non-licensees; that the Company must license its standard-essential patents on FRAND terms; and that the Company shall not, based on standard-essential patents, seek injunctions. The complaint also seeks damages of 10 million Taiwan Dollars (less than $1 million based on the exchange rate on March 25, 2018), among other relief.

On November 30, 2017, Apple and certain of its Chinese subsidiaries filed three patent infringement complaints against the Company in the Beijing Intellectual Property Court. Apple seeks damages and costs. The Company has filed jurisdictional objections to the complaints.

The Company believes Apple’s claims in the above matters are without merit.

QUALCOMM Incorporated v. Compal Electronics, Inc. et al.: On May 17, 2017, the Company filed a complaint in the United States District Court for the Southern District of California against Compal Electronics, Inc. (Compal), FIH Mobile, Ltd., Hon Hai Precision Industry Co., Ltd. (together with FIH Mobile, Ltd., Foxconn), Pegatron Corporation (Pegatron) and Wistron Corporation (Wistron) asserting claims for injunctive relief, specific performance, declaratory relief and damages stemming from the defendants’ breach of contracts by ceasing the payment of royalties for iPhones and other devices which they manufacture for Apple. On July 17, 2017, Compal, Foxconn, Pegatron and Wistron each filed third-party complaints for contractual indemnity against Apple seeking to join Apple as a party to the action. On July 18, 2017, Apple filed an answer to these third-party complaints acknowledging its indemnity agreements and consenting to be joined. On July 18, 2017, the defendants filed an Answer and Counterclaims to the complaint, asserting defenses and counterclaims similar to allegations previously made by Apple in the Apple Inc. v. QUALCOMM Incorporated case in the Southern District of California discussed above. In addition, the defendants asserted certain new claims, including claims under Section 1 of the Sherman Act and California’s Cartwright Act. The defendants seek damages, declaratory relief, injunctive relief, restitution of certain royalties and other relief. On July 18, 2017, Apple filed a motion to consolidate this action with the Apple Inc. v. QUALCOMM Incorporated case in the Southern District of California. On September 13, 2017, the court granted Apple’s consolidation motion. Fact discovery is set to close in these cases on May 11, 2018. A final pretrial conference is scheduled for September 28, 2018. No trial date has been set.

The Company believes Compal’s, Foxconn’s, Pegatron’s and Wistron’s claims in the above matter are without merit.

QUALCOMM Incorporated v. Apple Inc.: On July 6, 2017, the Company filed a complaint against Apple in the United States District Court for the Southern District of California asserting claims for damages and injunctive relief for infringement of six of the Company’s patents directed to a variety of features found in iPhone models. On July 7, 2017, the Company filed a complaint against Apple in the United States International Trade Commission (ITC) requesting that the ITC institute an investigation pursuant to Section 337 of the Tariff Act of 1930 based on Apple’s infringement of the same six patents. The Company is seeking a limited exclusion order and cease and desist order against importation of iPhone models that do not contain a Qualcomm brand baseband processor. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. Apple filed an Answer and Counterclaims in the District Court case on September 26, 2017. On November 29, 2017, Apple filed a First Amended Answer and Counterclaims asserting that the Company’s Snapdragon processors infringe eight Apple patents. On August 8, 2017, the ITC issued a notice of institution of an investigation. On August 25, 2017, the Company withdrew allegations as to one patent in both the ITC investigation and the District Court case. On April 25, 2018, the Company withdrew allegations as to two additional patents in the ITC investigation, but not the district court case, in order to satisfy certain briefing limitations and to narrow the issues for hearing. The ITC investigation is scheduled for evidentiary hearing by the Administrative Law Judge (ALJ) from June 18-26, 2018. The ALJ’s Initial Determination on the merits is due on September 14, 2018, and the target date for final determination by the ITC is set for January 14, 2019. A case management conference in the district court case was held on January 26, 2018. On March 2, 2018, the court granted the Company’s motion to sever, for separate trial, Apple’s counterclaims for patent infringement against the Company. With respect to the Company’s patent claims against Apple, fact discovery is scheduled to close on June 11, 2018 and trial is scheduled to begin on March 4, 2019. With respect to Apple’s patent claims against the Company, fact discovery is scheduled to close on December 3, 2018, and trial is scheduled to begin on July 15, 2019.

On November 1, 2017, the Company filed a complaint against Apple in San Diego Superior Court for breach of the Master Software Agreement between the companies. The complaint recounts instances when Apple failed to protect the Company’s software as required by the agreement and failed to provide sufficient information to which the Company is entitled under the agreement in order to understand whether other breaches have occurred. The complaint seeks specific performance of Apple’s obligations to cooperate with an audit of its handling of the Company’s software, damages and injunctive relief. Apple filed its Answer to the Complaint on December 29, 2017. A case management conference is scheduled for July 20, 2018. No trial date has been set.

On November 29, 2017, the Company filed three additional complaints against Apple in the United States District Court for the Southern District of California alleging infringement of a total of 16 of the Company’s patents. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. The complaints seek damages and injunctive relief. On January 22, 2018, Apple filed Answers and Counterclaims in each of these cases seeking declaratory judgments that the asserted patents are invalid and/or not infringed. Case management conferences were held on February 7, 2018 and March 1, 2018. Tutorials and presentation of claim construction arguments for two of the cases are scheduled for September 10 and 11, 2018 and October 10 and 11, 2018, respectively. For the case relating to the November 30, 2017 ITC investigation described below, a mandatory settlement conference is scheduled for October 19, 2018, fact discovery is scheduled to close on March 13, 2019, and trial is scheduled to begin on October 21, 2019. No trial date has been set for the other two cases.

On November 30, 2017, the Company filed a complaint in the ITC accusing certain Apple products of infringing five of the Company’s patents. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. The Company seeks a limited exclusion order and cease and desist order against importation of iPhone models that do not contain a Qualcomm brand baseband processor. On January 2, 2018, the ITC instituted an investigation. The ITC investigation is scheduled for evidentiary hearing by the Administrative Law Judge (ALJ) from September 17 through 21, 2018. The ALJ’s Initial Determination on the merits is due on January 22, 2019, and the target date for final determination by the ITC is set for May 22, 2019.

On July 17, 2017, the Company filed complaints against Apple and certain of its subsidiaries in the Federal Republic of Germany, asserting infringement of one of the Company’s patents in the Mannheim District Court and infringement of another patent in the Munich District Court. On October 2, 2017, the Company filed claim extensions in these actions against Apple and certain of its subsidiaries, asserting infringement of two additional patents in the Mannheim District Court and infringement of five additional patents in the Munich District Court. The complaints seek remedies including, among other relief, declaratory relief confirming liability on the merits for damages and injunctive relief. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms.

On September 29, 2017, the Company filed three complaints against Apple and certain of its subsidiaries in the Beijing (China) Intellectual Property Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms.

On November 13, 2017, the Company filed three complaints against certain of Apple’s subsidiaries in the Beijing (China) High People’s Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief, damages and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. On December 19, 2017, Apple’s subsidiaries filed invalidation requests with the Chinese Patent Review Board (PRB) for each of the three asserted patents. PRB hearings regarding the validity of the patents are scheduled for April and May 2018.

On November 15, 2017, the Company filed three complaints against certain of Apple’s subsidiaries in the Fuzhou (China) Intermediate People’s Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. The court has set hearings on the merits of infringement to begin on August 16, 2018 for one of the cases and August 18, 2018 for the other two cases. Apple’s subsidiaries filed invalidation requests with the Chinese Patent Review Board (PRB) on December 8, 2017 for one of the patents and December 11, 2017 for the other two patents. PRB hearings regarding the validity of the patents are scheduled for April and May 2018.

On January 12, 2018, the Company filed three additional complaints against Apple and certain of its subsidiaries in the Fuzhou (China) Intermediate People’s Court, asserting infringement of three additional Company patents. The complaints seek remedies including injunctive relief and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms.

Also on January 12, 2018, the Company filed three complaints against certain of Apple’s subsidiaries in the Jiangsu (China) High People’s Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief, damages and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. On February 5, 2018 and March 5, 2018, Apple’s subsidiaries filed invalidation requests with the PRB. PRB hearings regarding the validity of the patents are expected to begin in June 2018.

On February 2, 2018, the Company filed three additional complaints against certain of Apple’s subsidiaries in the Qingdao (China) Intermediate People’s Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. On February 26, 2018, Apple’s subsidiaries filed invalidation requests with the PRB. PRB hearings regarding the validity of the patents are expected to begin in June 2018.

Also on February 2, 2018, the Company filed three additional complaints against certain of Apple’s subsidiaries in the Guangzhou (China) Intermediate People’s Court, asserting infringement of three of the Company’s patents. The complaints seek remedies including injunctive relief and costs. The patents have not been declared as essential to any standards organization and are not subject to commitments to license on FRAND terms. On March 14, 2018, Apple’s subsidiaries filed invalidation requests with the PRB. PRB hearings regarding the validity of the patents are expected to begin in July 2018.

The Company believes Apple’s counterclaims and invalidation requests in the above matters are without merit.

3226701 Canada, Inc. v. QUALCOMM Incorporated et al: On November 30, 2015, plaintiffs filed a securities class action complaint against the Company and certain of its current and former officers in the United States District Court for the Southern District of California. On April 29, 2016, plaintiffs filed an amended complaint. On January 27, 2017, the court dismissed the amended complaint in its entirety, granting leave to amend. On March 17, 2017, plaintiffs filed a second amended complaint, alleging that the Company and certain of its current and former officers violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, as amended, by making false and misleading statements regarding the Company’s business outlook and product development between November 19, 2014 and July 22, 2015. The second amended complaint sought unspecified damages, interest, attorneys’ fees and other costs. On May 8, 2017, the Company filed a motion to dismiss the second amended complaint. On October 20, 2017, the court entered an order granting in part the Company’s motion to dismiss, and on November 29, 2017, the court entered an order granting the remaining portions of the Company’s motion to dismiss. On December 28, 2017, the plaintiffs filed a notice of appeal to the United States Court of Appeals for the Ninth Circuit. The Company believes the plaintiffs’ claims are without merit.

Consolidated Securities Class Action Lawsuit: On January 23, 2017 and January 26, 2017, securities class action complaints were filed by purported stockholders of the Company in the United States District Court for the Southern District of California against the Company and certain of its current and former officers and directors. The complaints alleged, among other things, that the defendants violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 thereunder, by making false and misleading statements and omissions of material fact in connection with certain allegations that the Company is or was engaged in anticompetitive conduct. The complaints sought unspecified damages, interest, fees and costs. On May 4, 2017, the court consolidated the two actions and appointed lead plaintiffs. On July 3, 2017, the lead plaintiffs filed a consolidated amended complaint asserting the same basic theories of liability and requesting the same basic relief. On September 1, 2017, the defendants filed a motion to dismiss the consolidated amended complaint. The court has not yet ruled on the motion. The Company believes the plaintiffs’ claims are without merit.

Consumer Class Action Lawsuit: Since January 18, 2017, a number of consumer class action complaints have been filed against the Company in the United States District Courts for the Southern and Northern Districts of California, each on behalf of a putative class of purchasers of cellular phones and other cellular devices. Twenty-two such cases remain outstanding. In April 2017, the Judicial Panel on Multidistrict Litigation transferred the cases that had been filed in the Southern District of California to the Northern District of California. On May 15, 2017, the court entered an order appointing the plaintiffs’ co-lead counsel, and on May 25, 2017, set a trial date of April 29, 2019. On July 11, 2017, the plaintiffs filed a consolidated amended complaint alleging that the Company violated California and federal antitrust and unfair competition laws by, among other things, refusing to license standard-essential patents to its competitors, conditioning the supply of certain of its baseband chipsets on the purchaser first agreeing to license the Company’s entire patent portfolio, entering into exclusive deals with companies including Apple Inc., and charging unreasonably high royalties that do not comply with the Company’s commitments to standard setting organizations. The complaint seeks unspecified damages and disgorgement and/or restitution, as well as an order that the Company be enjoined from further unlawful conduct. On August 11, 2017, the Company filed a motion to dismiss the consolidated amended complaint. On November 10, 2017, the court denied the Company’s motion to dismiss the consolidated amended complaint, except to the extent that certain claims seek damages under the Sherman Antitrust Act. Trial is scheduled to begin on January 19, 2019. The Company believes the plaintiffs’ claims are without merit.

Canadian Consumer Class Action Lawsuits: Since November 9, 2017, five consumer class action complaints have been filed against the Company in Canada alleging various violations of Canadian competition and consumer protection laws. The claims are similar to those in the FTC and U.S. consumer class action complaints. The complaints seek unspecified damages. The Company has not yet answered the complaints.

Hays v. Jacobs, et. al.: On May 24, 2017, the plaintiff filed a complaint in the United States District Court for the District of Delaware asserting derivative claims on behalf of the Company against certain of the Company’s current and former directors and officers. On November 13, 2017, the plaintiff filed an amended derivative complaint alleging that certain current and former directors and officers (i) breached their fiduciary duties by failing to oversee the Company’s operations, (ii) breached their fiduciary duties and Section 14(a) of the Securities Exchange Act of 1934, as amended, by making false and misleading statements regarding the Company’s business outlook, business practices and product development between November 6, 2013 and January 21, 2016 and (iii) were unjustly enriched as a result of the foregoing conduct. The amended complaint sought unspecified damages, interest, attorneys’ fees and other costs. The defendants filed a Motion to Dismiss the amended complaint, which was scheduled for hearing by the court on March 14, 2018. The parties filed a Joint Stipulation for Voluntary Dismissal and Proposed Order (the Order), which the court granted on March 9, 2018. Accordingly, the case has been dismissed, and the Order required this disclosure in this filing.

Japan Fair Trade Commission (JFTC) Complaint: The JFTC received unspecified complaints alleging that the Company’s business practices are, in some way, a violation of Japanese law. On September 29, 2009, the JFTC issued a cease and desist order concluding that the Company’s Japanese licensees were forced to cross-license patents to the Company on a royalty-free basis and were forced to accept a provision under which they agreed not to assert their essential patents against the Company’s other licensees who made a similar commitment in their license agreements with the Company. The cease and desist order seeks to require the Company to modify its existing license agreements with Japanese companies to eliminate these provisions while preserving the license of the Company’s patents to those companies. The Company disagrees with the conclusions that it forced its Japanese licensees to agree to any provision in the parties’ agreements and that those provisions violate the Japanese Antimonopoly Act. The Company has invoked its right under Japanese law to an administrative hearing before the JFTC. In February 2010, the Tokyo High Court granted the Company’s motion and issued a stay of the cease and desist order pending the administrative hearing before the JFTC. The JFTC has held hearings on 37 different dates. No further hearings are currently scheduled. Fines or other monetary remedies are not available in this matter.

Korea Fair Trade Commission (KFTC) Complaint: On January 4, 2010, the KFTC issued a written decision finding that the Company had violated Korean law by offering certain discounts and rebates for purchases of its CDMA chipsets and for including in certain agreements language requiring the continued payment of royalties after all licensed patents have expired. The KFTC levied a fine, which the Company paid and recorded as an expense in fiscal 2010. The Company appealed to the Seoul High Court, and on June 19, 2013, the Seoul High Court affirmed the KFTC’s decision. On July 4, 2013, the Company filed an appeal with the Korea Supreme Court. There have been no material developments since then with respect to this matter.

Korea Fair Trade Commission (KFTC) Investigation: On March 17, 2015, the KFTC notified the Company that it was conducting an investigation of the Company relating to the Korean Monopoly Regulation and Fair Trade Act (MRFTA). On December 27, 2016, the KFTC announced that it had reached a decision in the investigation, finding that the Company violated provisions of the MRFTA. On January 22, 2017, the Company received the KFTC’s formal written decision, which found that the following conducts violate the MRFTA: (i) refusing to license, or imposing restrictions on licenses for, cellular communications standard-essential patents with competing modem chipset makers; (ii) conditioning the supply of modem chipsets to handset suppliers on their execution and performance of license agreements with the Company; and (iii) coercing agreement terms including portfolio license terms, royalty terms and free cross-grant terms in executing patent license agreements with handset makers. The KFTC’s decision orders the Company to: (i) upon request by modem chipset companies, engage in good-faith negotiations for patent license agreements, without offering unjustifiable conditions, and if necessary submit to a determination of terms by an independent third party; (ii) not demand that handset companies execute and perform under patent license agreements as a precondition for purchasing modem chips; (iii) not demand unjustifiable conditions in the Company’s license agreements with handset companies, and upon request renegotiate existing patent license agreements; and (iv) notify modem chipset companies and handset companies of the decision and order imposed on the Company and report to the KFTC new or amended agreements. According to the KFTC’s decision, the foregoing will apply to transactions between the Company and the following enterprises: (i) handset manufacturers headquartered in Korea and their affiliate companies; (ii) enterprises that sell handsets in or to Korea and their affiliate companies; (iii) enterprises that supply handsets to companies referred to in (ii) above and the affiliate companies of such enterprises; (iv) modem chipset manufacturers headquartered in Korea and their affiliate companies; and (v) enterprises that supply modem chipsets to companies referred to in (i), (ii) or (iii) above and the affiliate companies of such enterprises. The KFTC’s decision also imposed a fine of approximately 1.03 trillion Korean Won (approximately $927 million), which was paid on March 30, 2017. The Company believes that its business practices do not violate the MRFTA, and on February 21, 2017 filed an action in the Seoul High Court to cancel the KFTC’s decision. On the same day, the Company filed an application with the Seoul High Court to stay the decision’s remedial order pending the Seoul High Court’s final judgment on the Company’s action to cancel the KFTC’s decision. On September 4, 2017, the Seoul High Court denied the Company’s application to stay the remedial order, and on November 27, 2017, the Korea Supreme Court dismissed the Company’s appeal of the Seoul High Court’s decision on the application to stay. The Seoul High Court has not ruled on the Company’s action to cancel the KFTC’s decision.

Icera Complaint to the European Commission (EC): On June 7, 2010, the EC notified and provided the Company with a redacted copy of a complaint filed with the EC by Icera, Inc. (subsequently acquired by Nvidia Corporation) alleging that the Company has engaged in anticompetitive activity. The Company was asked by the EC to submit a preliminary response to the portions of the complaint disclosed to it, and the Company submitted its response in July 2010. Subsequently, the Company provided additional documents and information as requested by the EC. On July 16, 2015, the EC announced that it had initiated formal proceedings in this matter. On December 8, 2015, the EC announced that it had issued a Statement of Objections expressing its preliminary view that between 2009 and 2011, the Company engaged in predatory pricing by selling certain baseband chipsets to two customers at prices below cost, with the intention of hindering competition. A Statement of Objections informs the subject of the investigation of the allegations against it and provides an opportunity to respond to such allegations. It is not a determination of the final outcome of the investigation. On August 15, 2016, the Company submitted its response to the Statement of Objections. If a violation is found, a broad range of remedies is potentially available to the EC, including imposing a fine and/or injunctive relief prohibiting or restricting certain business practices. It is difficult to predict the outcome of this matter or what remedies, if any, may be imposed by the EC. The Company believes that its business practices do not violate the European Union (EU) competition rules.

European Commission (EC) Investigation: On October 15, 2014, the EC notified the Company that it was conducting an investigation of the Company relating to Articles 101 and/or 102 of the Treaty on the Functioning of the European Union (TFEU). On July 16, 2015, the EC announced that it had initiated formal proceedings in this matter. On December 8, 2015, the EC announced that it had issued a Statement of Objections expressing its preliminary view that pursuant to an agreement with a customer, since 2011 the Company paid significant amounts to that customer on condition that it exclusively use the Company’s baseband chipsets in its smartphones and tablets. This conduct allegedly reduced the customer’s incentives to source chipsets from the Company’s competitors and harmed competition and innovation for certain baseband chipsets. On January 24, 2018, the EC issued a decision finding that certain terms of that agreement violate EU competition law and imposed a fine of approximately 997 million Euros. On April 6, 2018, the Company filed an appeal of the EC’s decision with the General Court of the European Union. The Company believes that its business practices do not violate the EU competition rules.

The Company recorded a charge of $1.18 billion to other expenses related to the EC fine in the first quarter of fiscal 2018. The Company intends to provide financial guarantees by April 30, 2018 to satisfy the obligation in lieu of cash payment while the Company appeals the EC’s decision. Beginning on April 30, 2018, the fine will accrue interest at a rate of 1.50% per annum until it has been paid or annulled. At March 25, 2018, the liability, including related foreign currency losses (which were recorded in investment and other income, net), was $1.23 billion and included in other current liabilities.

United States Federal Trade Commission (FTC) v. QUALCOMM Incorporated: On September 17, 2014, the FTC notified the Company that it is conducting an investigation of the Company relating to Section 5 of the Federal Trade Commission Act (FTCA). On January 17, 2017, the FTC filed a complaint against the Company in the United States District Court for the Northern District of California alleging that the Company engaged in anticompetitive conduct and unfair methods of competition in violation of Section 5 of the FTCA by conditioning the supply of baseband processors on the purchaser first agreeing to a license to the Company’s standard-essential patents, paying incentives to purchasers of baseband processors to induce them to accept certain license terms, refusing to license its standard-essential patents to the Company’s competitors and entering into alleged exclusive dealing arrangements with Apple Inc. The complaint seeks a permanent injunction against the Company’s alleged violations of the FTCA and other unspecified ancillary equitable relief. A fine is not an available remedy in this matter, and the Company does not believe that other monetary remedies are likely in this matter. On April 19, 2017, the court set a trial date for January 4, 2019. The Company believes the FTC’s claims are without merit.

Taiwan Fair Trade Commission (TFTC) Investigation: On December 4, 2015, the TFTC notified the Company that it was conducting an investigation into whether the Company’s patent licensing practices violate the Taiwan Fair Trade Act (TFTA). On April 27, 2016, the TFTC specified that the allegations under investigation included whether: (i) the Company jointly licensed its patents rather than separately licensing standard-essential patents and non-standard-essential patents; (ii) the Company’s royalty charges are unreasonable; (iii) the Company unreasonably required licensees to grant it cross-licenses; (iv) the Company failed to provide lists of licensed patents to licensees; (v) the Company violated a FRAND licensing commitment by declining to grant licenses to chipset makers; (vi) the Company declined to sell chipsets to unlicensed potential customers; and (vii) the Company provided royalty rebates to certain companies in exchange for their exclusive use of the Company’s chipsets. On October 11, 2017, the TFTC announced that it had reached a decision in the investigation, finding that the Company violated the TFTA. On October 23, 2017, the Company received TFTC’s formal written decision, which found that the following conducts violate the TFTA: (i) refusing to license and demanding restrictive covenants from chip competitors; (ii) refusing to supply baseband processors to companies that do not have an executed license; and (iii) providing a royalty discount to Apple in exchange for its exclusive use of the Company’s chipsets. The TFTC’s decision orders the Company to: (1) cease the following conduct within 60 days of the day after receipt of the decision: (a) applying the clauses in an agreement entered into with a competing chip supplier requesting it to provide sensitive sales information such as chip prices, customers, sales volumes, product types and serial numbers; (b) applying clauses in component supply agreements entered into with handset manufacturers relating to the refusal to sell chips to unlicensed manufacturers; and (c) applying discount clauses in the exclusive agreement entered into with a relevant enterprise; (2) notify competing chip companies and handset manufacturers in writing within 30 days after receipt of the decision that those companies may request to amend or enter into patent license agreements and other relevant agreements within 60 days of the day following the day such notices are received, and upon receipt of such requests, the Company shall commence negotiation in good faith; (3) submit status reports to the TFTC on any such negotiations every six months beginning from the day after receipt of the decision, as well as to submit a report to the TFTC within 30 days after amendments to any license agreements or newly signed license agreements are executed. The TFTC’s decision also imposed a fine of 23.4 billion Taiwan Dollars. The Company believes that its business practices do not violate the TFTA, and on November 10, 2017, the Company filed an Application for Stay of Enforcement of the TFTC’s decision in the Taiwan Intellectual Property Court (IPC). The TFTC filed an opposition brief on December 8, 2017, and the IPC held a hearing on December 11, 2017. The IPC has not yet ruled on the Company’s Application. On December 22, 2017, the Company filed an Administrative Litigation Complaint in the IPC to revoke the TFTC’s decision. The TFTC has not yet filed its response.

The Company recorded a charge of $778 million to other expenses related to the TFTC fine in the fourth quarter of fiscal 2017. The fine will be paid in monthly installments through December 2022. At March 25, 2018, the remaining liability, including related foreign currency losses (which were recorded in investment and other income, net), was approximately $771 million, of which $615 million was included in other noncurrent liabilities.

Contingent losses: The Company will continue to vigorously defend itself in the foregoing matters. However, litigation and investigations are inherently uncertain. Accordingly, the Company cannot predict the outcome of these matters. Other than with respect to the TFTC and EC fines, the Company has not recorded any accrual at March 25, 2018 for contingent losses associated with these matters based on its belief that losses, while possible, are not probable. Further, any possible range of loss cannot be reasonably estimated at this time. The unfavorable resolution of one or more of these matters could have a material adverse effect on the Company’s business, results of operations, financial condition or cash flows. The Company is engaged in numerous other legal actions not described above arising in the ordinary course of its business and, while there can be no assurance, believes that the ultimate outcome of these other legal actions will not have a material adverse effect on its business, results of operations, financial condition or cash flows.

Indemnifications. The Company generally does not indemnify its customers and licensees for losses sustained from infringement of third-party intellectual property rights. However, the Company is contingently liable under certain product sales, services, license and other agreements to indemnify certain customers, chipset foundries and semiconductor assembly and test service providers against certain types of liability and/or damages arising from qualifying claims of patent, copyright, trademark or trade secret infringement by products or services sold or provided by the Company, or by intellectual property provided by the Company to chipset foundries and semiconductor assembly and test service providers. The Company’s obligations under these agreements may be limited in terms of time and/or amount, and in some instances, the Company may have recourse against third parties for certain payments made by the Company.

Through March 25, 2018, the Company has received a number of claims from its direct and indirect customers and other third parties for indemnification under such agreements with respect to alleged infringement of third-party intellectual property rights by its products. Reimbursements under indemnification arrangements have not been material to the Company’s consolidated financial statements. The Company has not recorded any accrual for contingent liabilities at March 25, 2018 associated with these indemnification arrangements based on the Company’s belief that additional liabilities, while possible, are not probable. Further, any possible range of loss cannot be reasonably estimated at this time.

Purchase Obligations and Operating Leases. The Company has agreements with suppliers and other parties to purchase inventory, other goods and services and long-lived assets. Integrated circuit product inventory obligations represent purchase commitments for raw materials, semiconductor die, finished goods and manufacturing services, such as wafer bump, probe, assembly and final test. Under the Company’s manufacturing relationships with its foundry suppliers and assembly and test service providers, cancelation of outstanding purchase commitments is generally allowed but requires payment of costs incurred through the date of cancelation, and in some cases, incremental fees related to capacity underutilization.

The Company leases certain of its land, facilities and equipment under noncancelable operating leases, with terms ranging from less than one year to 21 years and with provisions in certain leases for cost-of-living increases.

Obligations under these purchase agreements and future minimum lease payments under these operating leases at March 25, 2018 were as follows:



	Integrated Circuit Purchase Obligations		Other Purchase Obligations		Operating Leases
Remainder of fiscal 2018	$	2,277	$	894	$	63
2019	1,074		286		114
2020	318		165		85
2021	63		60		64
2022	24		12		44
Thereafter	—		4		57
Total	$	3,756	$	1,421	$	427

Other Commitments. At March 25, 2018, the Company was committed to fund certain strategic investments up to $414 million, of which $77 million and $72 million is expected to be funded in the remainder of fiscal 2018 and in fiscal 2021, respectively. The remaining commitments do not have fixed funding dates and are subject to certain conditions. Commitments represent the maximum amounts to be funded under these arrangements; actual funding may be in lesser amounts or not at all.

In March 2018, the Company’s RF360 Holdings joint venture entered into an agreement for a build-to-suit construction project with a third-party lessor for the development of a manufacturing facility located in Singapore. The agreement includes a long-term lease commitment with a noncancelable 10-year term commencing upon completion of the construction project and four optional renewal terms of five years each. At March 25, 2018, the minimum lease commitment under the agreement based on the noncancelable term was approximately $90 million and the maximum lease commitment, including all optional renewal terms, was approximately $315 million.

Segment Information (Notes)

6 Months Ended

Mar. 25, 2018

Segment Reporting [Abstract]

Segment Information

The Company is organized on the basis of products and services and has three reportable segments. The Company conducts business primarily through its QCT (Qualcomm CDMA Technologies) semiconductor business and its QTL (Qualcomm Technology Licensing) licensing business. QCT develops and supplies integrated circuits and system software based on CDMA, OFDMA and other technologies for use in mobile devices, wireless networks, devices used in the Internet of Things (IoT), broadband gateway equipment, consumer electronic devices and automotive telematics and infotainment systems. QTL grants licenses to use portions of its intellectual property portfolio, which includes certain patent rights essential to and/or useful in the manufacture and sale of certain wireless products. The Company’s QSI (Qualcomm Strategic Initiatives) reportable segment makes strategic investments and includes revenues and related costs associated with development contracts with an equity method investee. The Company also has nonreportable segments, including its mobile health, data center, small cell and other wireless technology and service initiatives.

The Company evaluates the performance of its segments based on earnings (loss) before income taxes (EBT). In fiscal 2018, all of the costs related to pre-commercial research and development of 5G (fifth generation) technology, of which $115 million and $216 million was recorded in the three and six months ended March 25, 2018, respectively, are included in unallocated corporate research and development expenses, whereas similar costs related to the research and development of other technology, including 3G (third generation) and 4G (fourth generation) technology, were recorded in both the QCT and QTL segments.

The table below presents revenues, EBT and total assets for reportable segments (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Revenues
QCT	$	3,897		$	3,676		$	8,548		$	7,777
QTL	1,260			2,249			2,559			4,060
QSI	30			—			60			14
Reconciling items	74			(909		)	162			(836		)
Total	$	5,261		$	5,016		$	11,329		$	11,015
EBT
QCT	$	608		$	475		$	1,563		$	1,199
QTL	850			1,959			1,738			3,492
QSI	40			—			51			(17		)
Reconciling items	(1,140		)	(1,577		)	(3,020		)	(2,947		)
Total	$	358		$	857		$	332		$	1,727



	March 25, 2018		September 24, 2017
Assets
QCT	$	3,336	$	3,830
QTL	1,907		1,735
QSI	1,193		1,037
Reconciling items	57,690		58,884
Total	$	64,126	$	65,486

Reconciling items for revenues and EBT in the previous table were as follows (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Revenues
Nonreportable segments	$	74		$	65		$	162		$	138
Reduction to revenues related to BlackBerry arbitration decision	—			(974		)	—			(974		)
	$	74		$	(909	)	$	162		$	(836	)
EBT
Reduction to revenues related to BlackBerry arbitration decision	$	—		$	(974	)	$	—		$	(974	)
Unallocated cost of revenues	(111		)	(119		)	(228		)	(213		)
Unallocated research and development expenses	(271		)	(277		)	(551		)	(546		)
Unallocated selling, general and administrative expenses	(258		)	(138		)	(420		)	(283		)
Unallocated other expenses (Note 2)	(310		)	(78		)	(1,493		)	(954		)
Unallocated interest expense	(179		)	(106		)	(348		)	(195		)
Unallocated investment and other income, net	82			223			206			407
Nonreportable segments	(93		)	(108		)	(186		)	(189		)
	$	(1,140	)	$	(1,577	)	$	(3,020	)	$	(2,947	)

Unallocated acquisition-related expenses were comprised as follows (in millions):



	Three Months Ended				Six Months Ended
	March 25, 2018		March 26, 2017		March 25, 2018		March 26, 2017
Cost of revenues	$	102	$	106	$	208	$	191
Research and development expenses	2		12		3		14
Selling, general and administrative expenses	214		57		290		118

Acquisitions (Notes)	6 Months Ended
Acquisitions (Notes)	Mar. 25, 2018
Acquisitions [Abstract]
Acquisitions	Acquisitions On October 27, 2016, the Company announced a definitive agreement (the Purchase Agreement) under which Qualcomm River Holdings, B.V. (Qualcomm River Holdings), an indirect, wholly owned subsidiary of QUALCOMM Incorporated, will acquire NXP Semiconductors N.V. (NXP). NXP is a leader in high-performance, mixed-signal semiconductor electronics in automotive, broad-based microcontrollers, secure identification, network processing and RF power products. Pursuant to the Purchase Agreement, Qualcomm River Holdings has commenced a tender offer to acquire all of the issued and outstanding common shares of NXP. On February 20, 2018, Qualcomm River Holdings and NXP entered into Amendment No. 1 to the Purchase Agreement, which (i) increased the price payable in the tender offer from $110.00 per share in cash to $127.50 per share in cash, representing estimated total cash consideration to be paid to NXP’s shareholders of $44 billion, and (ii) reduced the Minimum Condition (as defined in the Purchase Agreement) from 80% of the issued and outstanding common shares of NXP to 70% of the issued and outstanding common shares of NXP. On April 19, 2018, Qualcomm River Holdings and NXP entered into Amendment No. 2 to the Purchase Agreement (Amendment No. 2), which, among other things, extended the End Date (as defined in the Purchase Agreement) from April 25, 2018 to July 25, 2018. The transaction is subject to receipt of regulatory clearance from the Ministry of Commerce in the People’s Republic of China (MOFCOM) and other closing conditions, including the tender of at least 70% of the issued and outstanding common shares of NXP in the tender offer. At an Extraordinary General Meeting of NXP’s shareholders held on January 27, 2017, NXP’s shareholders approved certain matters relating to the transaction, including the appointment of designees of Qualcomm River Holdings to NXP’s board of directors (effective upon the closing of the transaction) and certain transactions that are intended to be consummated after the completion of the tender offer. In May 2017, the Company issued an aggregate principal amount of $11.0 billion of unsecured floating- and fixed-rate notes with varying maturities, of which a portion will be used to fund the purchase price and other related transactions. In addition, the Company has secured $4.0 billion and $3.0 billion in committed financing through the 2016 Term Loan Facility and the 2018 Term Loan Facility, respectively, which are expected to be drawn on at the close of the NXP transaction. The Company has also secured $3.0 billion in committed financing through the 2018 Revolving Credit Facility, which is available, in part, to finance the transaction (Note 5). The remaining amount will be funded with cash held by foreign entities. Qualcomm River Holdings and NXP may terminate the Purchase Agreement under certain circumstances. If the Purchase Agreement is terminated in certain circumstances, including termination by NXP to enter into a superior proposal for an alternative acquisition transaction or a termination following a change of recommendation by NXP’s board of directors, NXP will be required to pay Qualcomm River Holdings a termination fee of $1.25 billion. If the Purchase Agreement is terminated under certain circumstances involving the failure to obtain the required regulatory approvals or the failure of NXP to complete certain pre-closing reorganization steps in all material respects, Qualcomm River Holdings will be required to pay NXP a termination fee of $2.0 billion. Under Amendment No. 2, in addition to its existing rights, NXP will be entitled to receive the termination fee (i) if the Purchase Agreement is terminated in accordance with its terms for any reason (subject to certain exceptions) and, at the time of any such termination, approval by MOFCOM, or in any jurisdiction where the parties’ previously obtained clearance will expire or where the applicable antitrust authority has required or requested a resubmission for clearance, has not been received, or (ii) at any time after July 25, 2018 if, at such time, approval by MOFCOM, or in any jurisdiction where the parties’ previously obtained clearance will expire or where the applicable antitrust authority has required or requested a resubmission for clearance, has not been received. In November 2016, as required by the Purchase Agreement, Qualcomm River Holdings entered into four letters of credit for an aggregate amount of $2.0 billion related to the potential termination fee payable to NXP. Pursuant to the terms of each letter of credit, NXP will have the right to draw amounts to fund certain termination compensation owed by Qualcomm River Holdings to NXP if the Purchase Agreement is terminated under certain circumstances, as described above. The letters of credit expire on June 30, 2018 or if drawn on by NXP or surrendered by Qualcomm River Holdings, provided that under Amendment No. 2, Qualcomm River Holdings is required to cause the letters of credit to be amended to, among other things, extend the expiration date. Each letter of credit is required to be fully cash collateralized in an amount equal to 100% of its face value through deposits with the issuers of the letters of credit. Qualcomm River Holdings is restricted from using the funds deposited as collateral while the letters of credit are outstanding. At March 25, 2018, the letters of credit were fully collateralized through bank time and demand deposits, which were included in other noncurrent assets.

Cost Plan (Notes)	6 Months Ended
Cost Plan (Notes)	Mar. 25, 2018
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	Note 9. Cost Plan On January 16, 2018, the Company announced a Cost Plan designed to align the Company’s cost structure to its long-term margin targets. As part of this plan, the Company has initiated a series of targeted actions across the Company’s businesses to reduce annual costs by $1 billion, excluding incremental costs resulting from any future acquisition of a business. The Company expects these cost reductions to be fully captured in fiscal 2019. In connection with this plan, the Company expects to incur total restructuring and restructuring-related charges of approximately $400 million to $525 million, which primarily consist of severance costs, and the majority of which are expected to be settled in cash. During the three months ended March 25, 2018, the Company recorded restructuring and restructuring-related charges of $310 million in other expenses (Note 2), which consisted of restructuring charges of $277 million, primarily related to severance costs, and restructuring-related charges of $33 million related to certain asset impairments. A negligible amount of cash payments was made related to this plan in the three months ended March 25, 2018.

Fair Value Measurements (Notes)

6 Months Ended

Mar. 25, 2018

Notes to Financial Statements [Abstract]

Fair Value Measurements

The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 25, 2018 (in millions):



	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	26,328	$	10,573	$	—	$	36,901
Marketable securities:
U.S. Treasury securities and government-related securities	10		2		—		12
Corporate bonds and notes	—		1,498		—		1,498
Mortgage- and asset-backed and auction rate securities	—		73		35		108
Equity and preferred securities and equity funds	40		—		—		40
Total marketable securities	50		1,573		35		1,658
Derivative instruments	—		7		—		7
Other investments	408		—		13		421
Total assets measured at fair value	$	26,786	$	12,153	$	48	$	38,987
Liabilities
Derivative instruments	$	—	$	65	$	—	$	65
Other liabilities	408		—		194		602
Total liabilities measured at fair value	$	408	$	65	$	194	$	667

Activity between Levels of the Fair Value Hierarchy. There were no transfers between Level 1 and Level 2 in the six months ended March 25, 2018 and March 26, 2017. There were no transfers of marketable securities into or out of Level 3 during the six months ended March 25, 2018 and March 26, 2017. Other investments and other liabilities included in Level 3 at March 25, 2018 were comprised of convertible debt instruments issued by private companies and contingent consideration related to business combinations, respectively. There were no transfers of convertible debt instruments or contingent consideration amounts into or out of Level 3 during the six months ended March 25, 2018 and March 26, 2017.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Marketable Securities (Notes)

6 Months Ended

Mar. 25, 2018

Marketable Securities [Abstract]

Marketable Securities

Marketable securities were comprised as follows (in millions):



	Current				Noncurrent
	March 25, 2018		September 24, 2017		March 25, 2018		September 24, 2017
Available-for-sale:
U.S. Treasury securities and government-related securities	$	12	$	23	$	—	$	959
Corporate bonds and notes	1,498		2,014		—		271
Mortgage- and asset-backed and auction rate securities	73		93		35		40
Equity and preferred securities and equity funds	40		36		—		—
Debt funds	—		109		—		—
Total available-for-sale	1,623		2,275		35		1,270
Time deposits	2		4		—		—
Total marketable securities	$	1,625	$	2,279	$	35	$	1,270

The contractual maturities of available-for-sale debt securities were as follows (in millions):



	March 25, 2018
Years to Maturity
Less than one year	$	610
One to five years	900
Five to ten years	—
Greater than ten years	—
No single maturity date	108
Total	$	1,618

Debt securities with no single maturity date included mortgage- and asset-backed securities and auction rate securities.

The Company recorded realized gains and losses on sales of available-for-sale securities as follows (in millions):



	For the three months ended				For the six months ended
	March 25, 2018		March 26, 2017		March 25, 2018		March 26, 2017
Gross realized gains	$	11	$	57	$	13	$	303
Gross realized losses	—		—		—		(107		)
Net realized gains	$	11	$	57	$	13	$	196

Available-for-sale securities were comprised as follows (in millions):



	March 25, 2018			September 24, 2017
Equity securities
Cost	$	8		$	8
Unrealized gains	32			28
Fair value	40			36
Debt securities (including debt funds)
Cost	1,621			3,497
Unrealized gains	3			13
Unrealized losses	(6		)	(1		)
Fair value	1,618			3,509
	$	1,658		$	3,545

In connection with the proposed NXP transaction (Note 8), the Company divested a substantial portion of its marketable securities portfolio in order to finance, in part, that transaction. Marketable securities that are expected to be used to finance the NXP transaction were fully liquidated and classified as cash and cash equivalents at March 25, 2018. Given the Company’s intention to sell certain marketable securities, the Company recorded other-than-temporary impairment losses in fiscal 2017 for certain marketable securities and no additional losses were recorded in the six months ended March 25, 2018 (Note 2). For the available-for-sale securities that are not expected to be sold to finance the NXP transaction, the Company concluded that the unrealized losses were temporary at March 25, 2018. Further, for debt securities with unrealized losses, the Company did not have the intent to sell, nor was it more likely than not that the Company would be required to sell, such securities before recovery or maturity.

Basis of Presentation (Policies)	6 Months Ended
Basis of Presentation (Policies)	Mar. 25, 2018
Basis of Presentation [Abstract]
Fiscal Period, Policy	The Company operates and reports using a 52-53 week fiscal year ending on the last Sunday in September. Each of the three-month and six-month periods ended March 25, 2018 and March 26, 2017 included 13 weeks and 26 weeks, respectively.
Use of Estimates, Policy	The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company’s condensed consolidated financial statements and the accompanying notes. Actual results could differ from those estimates.
Earnings Per Share, Policy	Earnings (Loss) Per Common Share. Basic earnings (loss) per common share is computed by dividing net income (loss) attributable to Qualcomm by the weighted-average number of common shares outstanding during the reporting period. Diluted earnings per share is computed by dividing net income attributable to Qualcomm by the combination of dilutive common share equivalents, comprised of shares issuable under the Company’s share-based compensation plans, if any, and the weighted-average number of common shares outstanding during the reporting period. Due to the net loss for the six months ended March 25, 2018, all of the common share equivalents issuable under share-based compensation plans had an anti-dilutive effect and were therefore excluded from the computation of diluted loss per share.
Recent Accounting Pronouncements, Policy	Recent Accounting Pronouncements. Share-based Awards: In March 2016, the Financial Accounting Standards Board (FASB) issued new guidance that changed the accounting for share-based awards, including income taxes, classification of awards and classification in the statement of cash flows. The Company adopted the new guidance in the first quarter of fiscal 2018. In accordance with the new guidance, excess tax benefits or deficiencies associated with share-based awards are recognized through earnings when the awards vest or settle, rather than in stockholders’ equity. In the six months ended March 25, 2018, net excess tax benefits associated with share-based awards of $21 million were recognized in the Company’s income tax provision. In addition, cash flows related to excess tax benefits are presented as an operating activity and cash payments made on an employee’s behalf for withheld shares are presented as financing activities, with the prior periods adjusted accordingly. As a result of these changes, amounts for the six months ended March 26, 2017 have been adjusted as follows: net cash provided by operating activities increased by $212 million with a corresponding offset to net cash used in financing activities. The new guidance also impacts the Company’s earnings per share calculation as the estimate of dilutive common share equivalents under the treasury stock method no longer assumes that the estimated tax benefits realized when an award is settled are used to repurchase shares. There was no impact of this change on the Company’s calculation of earnings per share as a result of the net loss for the six months ended March 25, 2018. The Company elected to continue its practice of estimating forfeitures expected to occur in determining the amount of compensation cost to be recognized each period. Revenue Recognition: In May 2014, the FASB issued new guidance related to revenue recognition, which outlines a comprehensive revenue recognition model and supersedes most current revenue recognition guidance. The new guidance requires a company to recognize revenue as control of goods or services transfers to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. It defines a five-step approach for recognizing revenue, which may require a company to use more judgment and make more estimates than under the current guidance. The Company will adopt the new guidance in the first quarter of fiscal 2019 using the modified retrospective approach, with the cumulative effect of applying the new guidance recognized as an adjustment to the opening retained earnings balance. Given the scope of work required to implement the recognition and disclosure requirements under the new guidance, the Company has made progress in the identification of changes to policy, processes, systems and controls, and the Company continues to assess data availability and presentation necessary to meet the additional disclosure requirements of the guidance in the notes to the consolidated financial statements. The Company currently expects the adoption of this new guidance to most significantly impact its licensing business. Specifically, the Company expects a change in the timing of revenues recognized from sales-based royalties. The Company currently recognizes sales-based royalties as revenues in the period in which such royalties are reported by licensees, which is after the conclusion of the quarter in which the licensees’ sales occur and when all other revenue recognition criteria are met. Under the new guidance, the Company will be required to estimate and recognize sales-based royalties in the period in which the associated sales occur, resulting in an acceleration of revenue recognition compared to the current method. Upon adoption of the new guidance, licenses to use portions of the Company’s intellectual property portfolio will be considered one performance obligation, and license fees will be recognized as revenues on a straight-line basis over the term of the license agreement, which is similar to the recognition of license revenues under the current guidance. The Company currently accounts for customer incentive arrangements in its licensing and semiconductor businesses, including volume-related and other pricing rebates or cost reimbursements for marketing and other activities involving certain of the Company’s products and technologies, in part based on the maximum potential liability. Under the new guidance, the Company will estimate the amount of all customer incentives. The Company does not otherwise expect the adoption of the new guidance to have a material impact on its businesses. Financial Assets: In January 2016, the FASB issued new guidance on classifying and measuring financial instruments, which requires that (i) all equity investments, other than equity-method investments, in unconsolidated entities generally be measured at fair value through earnings and (ii) when the fair value option has been elected for financial liabilities, changes in fair value due to instrument-specific credit risk be recognized separately in other comprehensive income. Additionally, it changes the disclosure requirements for financial instruments. The Company will adopt the new guidance in the first quarter of fiscal 2019 and is in the process of determining the effects the adoption will have on its consolidated financial statements. In June 2016, the FASB issued new guidance that changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The new guidance will be effective for the Company starting in the first quarter of fiscal 2021. Early adoption is permitted starting in the first quarter of fiscal 2020. The Company is in the process of determining the effects the adoption will have on its consolidated financial statements and whether to adopt the new guidance early. Leases: In February 2016, the FASB issued new guidance related to leases that outlines a comprehensive lease accounting model and supersedes the current lease guidance. The new guidance requires lessees to recognize lease liabilities and corresponding right-of-use assets for all leases with lease terms of greater than 12 months. It also changes the definition of a lease and expands the disclosure requirements of lease arrangements. The Company will adopt the new guidance in the first quarter of fiscal 2020 and expects to use the modified retrospective approach, with the cumulative effect of applying the new guidance recognized as an adjustment to opening retained earnings in the year of adoption. The Company is in the process of determining the effects the adoption will have on its consolidated financial statements and whether to apply any of the optional practical expedients. Hedge Instruments: In August 2017, the FASB issued new guidance that expands and refines hedge accounting for both financial and non-financial risks, aligns the recognition and presentation of the effects of hedging instruments and hedged items in the financial statements, and includes targeted improvements related to the assessment of hedge effectiveness. The new guidance also modifies disclosure requirements for hedging activities. The Company plans to adopt the new guidance in the first quarter of fiscal 2019 and does not expect the effects of the adoption to have a material impact on its consolidated financial statements. Other: In August 2016, the FASB issued new guidance related to the classification of certain cash receipts and cash payments on the statement of cash flows. The Company will adopt the new guidance in the first quarter of fiscal 2019 and does not expect the effects of the adoption to have a material impact on its consolidated statements of cash flows. In October 2016, the FASB issued new guidance that changes the accounting for income tax effects of intra-entity transfers of assets other than inventory. Under the new guidance, the selling (transferring) entity is required to recognize a current tax expense or benefit upon transfer of the asset. Similarly, the purchasing (receiving) entity is required to recognize a deferred tax asset or deferred tax liability, as well as the related deferred tax benefit or expense, upon receipt of the asset. The Company will adopt the new guidance in the first quarter of fiscal 2019 and is in the process of determining the effects the adoption will have on its consolidated financial statements.
Segment Reporting, Policy	The Company evaluates the performance of its segments based on earnings (loss) before income taxes (EBT).

Basis of Presentation (Tables)

6 Months Ended

Mar. 25, 2018

Basis of Presentation [Abstract]

Schedule of diluted earnings per share

The following table provides information about the diluted earnings per share calculation (in millions):



	Three Months Ended		Six Months Ended
	March 25, 2018	March 26, 2017	March 25, 2018	March 26, 2017
Dilutive common share equivalents included in diluted shares	12.2	11.3	—	14.2
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period	0.1	10.8	44.9	5.4

Share-based compensation expense related to all share-based awards

Total share-based compensation expense, related to all of the Company’s share-based awards, was comprised as follows (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Cost of revenues	$	10		$	10		$	21		$	20
Research and development	151			155			307			308
Selling, general and administrative	61			81			142			157
Share-based compensation expense before income taxes	222			246			470			485
Related income tax benefit	(29		)	(36		)	(77		)	(84		)
	$	193		$	210		$	393		$	401

Composition of Certain Financial Statement Items (Tables)

6 Months Ended

Mar. 25, 2018

Balance Sheet Related Disclosures [Abstract]

Inventories



Inventories (in millions)
	March 25, 2018		September 24, 2017
Raw materials	$	93	$	103
Work-in-process	643		799
Finished goods	1,061		1,133
	$	1,797	$	2,035

Other Current Liabilities



Other Current Liabilities (in millions)
	March 25, 2018		September 24, 2017
Customer incentives and other customer-related liabilities	$	2,882	$	2,804
Accrual for EC fine (Note 6)	1,232		—
Income taxes payable	575		312
Accrual for TFTC fine (Note 6)	156		778
Other	864		862
	$	5,709	$	4,756

Investment and Other Income, Net



Investment and Other Income, Net (in millions)
	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Interest and dividend income	$	154		$	153		$	280		$	320
Net realized gains on marketable securities	3			67			13			206
Net realized gains on other investments	47			21			60			30
Impairment losses on marketable securities	—			(3		)	(1		)	(125		)
Impairment losses on other investments	(11		)	(2		)	(19		)	(23		)
Net gains on derivative investments	10			13			9			20
Equity in net losses of investees	(17		)	(14		)	(38		)	(11		)
Net losses on foreign currency transactions	(90		)	—			(93		)	—
	$	96		$	235		$	211		$	417

Stockholders' Equity (Tables)

6 Months Ended

Mar. 25, 2018

Stockholders' Equity Attributable to Parent [Abstract]

Changes in Stockholders Equity

Changes in stockholders’ equity in the six months ended March 25, 2018 were as follows (in millions):



	Total Stockholders’ Equity
Balance at September 24, 2017	$	30,746
Net loss	(5,590		)
Other comprehensive income	161
Common stock issued under employee benefit plans and related tax benefits	343
Share-based compensation	499
Tax withholdings related to vesting of share-based payments	(196		)
Dividends	(1,719		)
Stock repurchases	(425		)
Balance at March 25, 2018	$	23,819

Changes in Accumulated Other Comprehensive Income

Changes in the components of accumulated other comprehensive income, net of income taxes, in stockholders’ equity in the six months ended March 25, 2018 were as follows (in millions):



	Foreign Currency Translation Adjustment		Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities		Net Unrealized Gain (Loss) on Other Available-for-Sale Securities			Net Unrealized (Loss) Gain on Derivative Instruments			Other Gains		Total Accumulated Other Comprehensive Income
Balance at September 24, 2017	$	147	$	23	$	218		$	(8	)	$	4	$	384
Other comprehensive income (loss) before reclassifications	173		—		(1		)	(6		)	—		166
Reclassifications from accumulated other comprehensive income	—		1		(9		)	3			—		(5		)
Other comprehensive income (loss)	173		1		(10		)	(3		)	—		161
Balance at March 25, 2018	$	320	$	24	$	208		$	(11	)	$	4	$	545

Stockholders' Equity Dividends (Tables)

6 Months Ended

Mar. 25, 2018

Dividends [Abstract]

Dividends Declared

In the six months ended March 25, 2018 and March 26, 2017, dividends charged to retained earnings were as follows (in millions, except per share data):



	2018				2017
	Per Share		Total		Per Share		Total
First quarter	$	0.57	$	862	$	0.53	$	801
Second quarter	0.57		857		0.53		798
	$	1.14	$	1,719	$	1.06	$	1,599

Debt (Tables)

6 Months Ended

Mar. 25, 2018

Debt Disclosure [Abstract]

Schedule of long-term debt

The following table provides a summary of the Company’s long-term debt (in millions, except percentages):



		March 25, 2018				September 24, 2017
		Amount			Effective Rate	Amount			Effective Rate
May 2015 Notes
	Floating-rate three-month LIBOR plus 0.27% notes due May 18, 2018	$	250		2.21%	$	250		1.65%
	Floating-rate three-month LIBOR plus 0.55% notes due May 20, 2020	250			2.49%	250			1.92%
	Fixed-rate 1.40% notes due May 18, 2018	1,250			2.94%	1,250			1.93%
	Fixed-rate 2.25% notes due May 20, 2020	1,750			2.79%	1,750			2.20%
	Fixed-rate 3.00% notes due May 20, 2022	2,000			3.34%	2,000			2.65%
	Fixed-rate 3.45% notes due May 20, 2025	2,000			3.46%	2,000			3.46%
	Fixed-rate 4.65% notes due May 20, 2035	1,000			4.74%	1,000			4.74%
	Fixed-rate 4.80% notes due May 20, 2045	1,500			4.71%	1,500			4.71%
May 2017 Notes
	Floating-rate three-month LIBOR plus 0.36% notes due May 20, 2019	750			2.37%	750			1.80%
	Floating-rate three-month LIBOR plus 0.45% notes due May 20, 2020	500			2.43%	500			1.86%
	Floating-rate three-month LIBOR plus 0.73% notes due January 30, 2023	500			2.56%	500			2.11%
	Fixed-rate 1.85% notes due May 20, 2019	1,250			2.00%	1,250			2.00%
	Fixed-rate 2.10% notes due May 20, 2020	1,500			2.19%	1,500			2.19%
	Fixed-rate 2.60% notes due January 30, 2023	1,500			2.70%	1,500			2.70%
	Fixed-rate 2.90% notes due May 20, 2024	1,500			3.01%	1,500			3.01%
	Fixed-rate 3.25% notes due May 20, 2027	2,000			3.46%	2,000			3.46%
	Fixed-rate 4.30% notes due May 20, 2047	1,500			4.47%	1,500			4.47%
Total principal		21,000				21,000
	Unamortized discount, including debt issuance costs	(97		)		(106		)
	Hedge accounting fair value adjustments	(43		)		—
	Total	$	20,860			$	20,894
Reported as:
	Short-term debt	$	1,499			$	1,496
	Long-term debt	19,361				19,398
	Total	$	20,860			$	20,894

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21475-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 4: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=64930739&loc=d3e28878-108400

Reference 6: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21538-112644

Reference 7: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28541-108399

Reference 9: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=64930785&loc=d3e28551-108399

Reference 10: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=84159872&loc=d3e21521-112644

+ Details

Commitments and Contingencies (Tables)

6 Months Ended

Mar. 25, 2018

Commitments and Contingencies Disclosure [Abstract]

Schedule of obligations under purchase agreements and future minimums lease payments under operating leases

Obligations under these purchase agreements and future minimum lease payments under these operating leases at March 25, 2018 were as follows:



	Integrated Circuit Purchase Obligations		Other Purchase Obligations		Operating Leases
Remainder of fiscal 2018	$	2,277	$	894	$	63
2019	1,074		286		114
2020	318		165		85
2021	63		60		64
2022	24		12		44
Thereafter	—		4		57
Total	$	3,756	$	1,421	$	427

Segment Information (Tables)

6 Months Ended

Mar. 25, 2018

Segment Reporting [Abstract]

Revenues, EBT and Total Assets for reportable segments

The table below presents revenues, EBT and total assets for reportable segments (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Revenues
QCT	$	3,897		$	3,676		$	8,548		$	7,777
QTL	1,260			2,249			2,559			4,060
QSI	30			—			60			14
Reconciling items	74			(909		)	162			(836		)
Total	$	5,261		$	5,016		$	11,329		$	11,015
EBT
QCT	$	608		$	475		$	1,563		$	1,199
QTL	850			1,959			1,738			3,492
QSI	40			—			51			(17		)
Reconciling items	(1,140		)	(1,577		)	(3,020		)	(2,947		)
Total	$	358		$	857		$	332		$	1,727



	March 25, 2018		September 24, 2017
Assets
QCT	$	3,336	$	3,830
QTL	1,907		1,735
QSI	1,193		1,037
Reconciling items	57,690		58,884
Total	$	64,126	$	65,486

Reconciling items for reportable segments - revenues

Reconciling items for revenues and EBT in the previous table were as follows (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Revenues
Nonreportable segments	$	74		$	65		$	162		$	138
Reduction to revenues related to BlackBerry arbitration decision	—			(974		)	—			(974		)
	$	74		$	(909	)	$	162		$	(836	)
EBT
Reduction to revenues related to BlackBerry arbitration decision	$	—		$	(974	)	$	—		$	(974	)
Unallocated cost of revenues	(111		)	(119		)	(228		)	(213		)
Unallocated research and development expenses	(271		)	(277		)	(551		)	(546		)
Unallocated selling, general and administrative expenses	(258		)	(138		)	(420		)	(283		)
Unallocated other expenses (Note 2)	(310		)	(78		)	(1,493		)	(954		)
Unallocated interest expense	(179		)	(106		)	(348		)	(195		)
Unallocated investment and other income, net	82			223			206			407
Nonreportable segments	(93		)	(108		)	(186		)	(189		)
	$	(1,140	)	$	(1,577	)	$	(3,020	)	$	(2,947	)

Reconciling items for reportable segments - Revenues and EBT

Reconciling items for revenues and EBT in the previous table were as follows (in millions):



	Three Months Ended						Six Months Ended
	March 25, 2018			March 26, 2017			March 25, 2018			March 26, 2017
Revenues
Nonreportable segments	$	74		$	65		$	162		$	138
Reduction to revenues related to BlackBerry arbitration decision	—			(974		)	—			(974		)
	$	74		$	(909	)	$	162		$	(836	)
EBT
Reduction to revenues related to BlackBerry arbitration decision	$	—		$	(974	)	$	—		$	(974	)
Unallocated cost of revenues	(111		)	(119		)	(228		)	(213		)
Unallocated research and development expenses	(271		)	(277		)	(551		)	(546		)
Unallocated selling, general and administrative expenses	(258		)	(138		)	(420		)	(283		)
Unallocated other expenses (Note 2)	(310		)	(78		)	(1,493		)	(954		)
Unallocated interest expense	(179		)	(106		)	(348		)	(195		)
Unallocated investment and other income, net	82			223			206			407
Nonreportable segments	(93		)	(108		)	(186		)	(189		)
	$	(1,140	)	$	(1,577	)	$	(3,020	)	$	(2,947	)

Unallocated acquisition-related expenses were comprised as follows (in millions):



	Three Months Ended				Six Months Ended
	March 25, 2018		March 26, 2017		March 25, 2018		March 26, 2017
Cost of revenues	$	102	$	106	$	208	$	191
Research and development expenses	2		12		3		14
Selling, general and administrative expenses	214		57		290		118

Fair Value Measurements (Tables)

6 Months Ended

Mar. 25, 2018

Notes to Financial Statements [Abstract]

Fair value hierarchy for assets and liabilities measured at fair value on a recurring basis

The following table presents the Company’s fair value hierarchy for assets and liabilities measured at fair value on a recurring basis at March 25, 2018 (in millions):



	Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	26,328	$	10,573	$	—	$	36,901
Marketable securities:
U.S. Treasury securities and government-related securities	10		2		—		12
Corporate bonds and notes	—		1,498		—		1,498
Mortgage- and asset-backed and auction rate securities	—		73		35		108
Equity and preferred securities and equity funds	40		—		—		40
Total marketable securities	50		1,573		35		1,658
Derivative instruments	—		7		—		7
Other investments	408		—		13		421
Total assets measured at fair value	$	26,786	$	12,153	$	48	$	38,987
Liabilities
Derivative instruments	$	—	$	65	$	—	$	65
Other liabilities	408		—		194		602
Total liabilities measured at fair value	$	408	$	65	$	194	$	667

Marketable Securities (Tables)

6 Months Ended

Mar. 25, 2018

Marketable Securities [Abstract]

Composition of marketable securities

Marketable securities were comprised as follows (in millions):



	Current				Noncurrent
	March 25, 2018		September 24, 2017		March 25, 2018		September 24, 2017
Available-for-sale:
U.S. Treasury securities and government-related securities	$	12	$	23	$	—	$	959
Corporate bonds and notes	1,498		2,014		—		271
Mortgage- and asset-backed and auction rate securities	73		93		35		40
Equity and preferred securities and equity funds	40		36		—		—
Debt funds	—		109		—		—
Total available-for-sale	1,623		2,275		35		1,270
Time deposits	2		4		—		—
Total marketable securities	$	1,625	$	2,279	$	35	$	1,270

Contractual maturities of available-for-sale debt securities

The contractual maturities of available-for-sale debt securities were as follows (in millions):



	March 25, 2018
Years to Maturity
Less than one year	$	610
One to five years	900
Five to ten years	—
Greater than ten years	—
No single maturity date	108
Total	$	1,618

Realized gains and losses on sales of available-for-sale securities

The Company recorded realized gains and losses on sales of available-for-sale securities as follows (in millions):



	For the three months ended				For the six months ended
	March 25, 2018		March 26, 2017		March 25, 2018		March 26, 2017
Gross realized gains	$	11	$	57	$	13	$	303
Gross realized losses	—		—		—		(107		)
Net realized gains	$	11	$	57	$	13	$	196

Composition of available-for-sale securities

Available-for-sale securities were comprised as follows (in millions):



	March 25, 2018			September 24, 2017
Equity securities
Cost	$	8		$	8
Unrealized gains	32			28
Fair value	40			36
Debt securities (including debt funds)
Cost	1,621			3,497
Unrealized gains	3			13
Unrealized losses	(6		)	(1		)
Fair value	1,618			3,509
	$	1,658		$	3,545

Basis of Presentation Earnings (Loss) Per Common Share (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Basis of Presentation [Abstract]
Dilutive common share equivalents included in diluted shares	12.2	11.3	0.0	14.2
Shares of common stock equivalents not included because the effect would be anti-dilutive or certain performance conditions were not satisfied at the end of the period	0.1	10.8	44.9	5.4

Basis of Presentation Share-Based Compensation (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense before income taxes	$ 222	$ 246	$ 470	$ 485
Related income tax benefit	(29)	(36)	(77)	(84)
Share-based compensation expense, net of income taxes	193	210	393	401
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Unrecognized compensation costs related to non-vested restricted stock units	$ 1,300		$ 1,300
Weighted-average period over which unrecognized compensation expense related to nonvested restricted stock units is expected to be recognized			1 year 11 months
RSUs outstanding	28.4		28.4
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock options outstanding	7.8		7.8
Cost of revenues [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense before income taxes	$ 10	10	$ 21	20
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense before income taxes	151	155	307	308
Selling, general and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense before income taxes	$ 61	$ 81	$ 142	$ 157

Basis of Presentation New Accounting Pronouncements (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income benefit (expense)	$ 5	$ (108)	$ (5,922)	$ (296)
Accounting Standards Update 2016-09 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Income benefit (expense)			$ 21
Adjustments to prior year cash used in financing activities				(212)
Adjustment to prior year cash provided by operating activities				$ 212

Composition of Certain Financial Statement Items Inventories (Details) - USD ($) $ in Millions	Mar. 25, 2018	Sep. 24, 2017
Inventory, Net [Abstract]
Raw materials	$ 93	$ 103
Work-in-process	643	799
Finished goods	1,061	1,133
Inventories	$ 1,797	$ 2,035

Composition of Certain Financial Statement Items Other Current Liabilities (Details) - USD ($) $ in Millions	Mar. 25, 2018	Sep. 24, 2017
Other Current Liabilities [Line Items]
Customer incentives and other customer-related liabilities	$ 2,882	$ 2,804
Income taxes payable	575	312
Other	864	862
EC [Member]
Other Current Liabilities [Line Items]
Loss contingency, accrual, current	1,232	0
TFTC [Member]
Other Current Liabilities [Line Items]
Loss contingency, accrual, current	$ 156	$ 778

Composition of Certain Financial Statement Items Other Income, Costs and Expenses (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended		12 Months Ended
	Mar. 25, 2018	Dec. 24, 2017	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017	Sep. 24, 2017
Restructuring and restructuring-related charges	$ 310		$ 25		$ 33
EC [Member]
Loss contingency, loss in period		$ 1,180		$ 1,180
KFTC [Member]
Loss contingency, loss in period					$ 921	$ 927
Foreign currency losses related to KFTC accrual			$ 53

Composition of Certain Financial Statement Items Investment and Other Income, Net (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Investment Income, Net [Abstract]
Interest and dividend income	$ 154	$ 153	$ 280	$ 320
Net realized gains on marketable securities	3	67	13	206
Net realized gains on other investments	47	21	60	30
Impairment losses on marketable securities	0	(3)	(1)	(125)
Impairment losses on other investments	(11)	(2)	(19)	(23)
Net gains on derivative investments	10	13	9	20
Equity in net losses of investees	(17)	(14)	(38)	(11)
Net losses on foreign currency transactions	(90)	0	(93)	0
Investment and other income, net	$ 96	$ 235	$ 211	$ 417

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended			6 Months Ended		9 Months Ended	12 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Mar. 25, 2018	Dec. 24, 2017	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017	Sep. 30, 2018	Sep. 30, 2018	Sep. 24, 2017
Income Taxes [Line Items]
Income tax expense (benefit)	$ (5)		$ 108	$ 5,922	$ 296
Current income taxes payable	$ 575			575				$ 312
Effective income tax rate (benefit)	(1.00%)							18.00%
Tax benefits from foreign income taxed at rates lower than rates in the United States								32.00%
Unrecognized tax benefits	$ 347			347				$ 372
Scenario, Forecast [Member]
Income Taxes [Line Items]
Effective income tax rate (benefit)							438.00%
Tax benefits from foreign income taxed at rates lower than rates in the United States							31.00%
U.S. Tax Cuts and Jobs Act Effective 2018 [Member]
Income Taxes [Line Items]
Income tax expense (benefit)	(15)	$ 5,870
Toll charge		5,300		5,300
Impact of remeasurement of U.S. deferred tax assets and liabilities		562		540
Foreign withholding tax from decision to no longer indefinitely reinvest certain foreign earnings		86		93
Income taxes payable	3,200			3,200
Current income taxes payable	251			251
U.S. Tax Cuts and Jobs Act Effective 2018 [Member] \| Scenario, Forecast [Member]
Income Taxes [Line Items]
Federal statutory income tax rate						21.00%	25.00%
Internal Revenue Service (IRS) [Member]
Income Taxes [Line Items]
Tax credit carryforward, amount	$ 1,100			1,100
Combined Effect of Certain Components Tax Legislation
Income Taxes [Line Items]
Income tax expense (benefit)		$ 5,960		$ 5,950

Stockholders' Equity Changes in Stockholders' Equity (Details) - USD ($) $ in Millions	3 Months Ended				6 Months Ended
	Mar. 25, 2018	Dec. 24, 2017	Mar. 26, 2017	Dec. 25, 2016	Mar. 25, 2018	Mar. 26, 2017
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Balance at beginning of the period		$ 30,746			$ 30,746
Net income (loss)	$ 363		$ 749		(5,590)	$ 1,431
Other comprehensive income	160		43		161	(198)
Common stock issued under employee benefit plans and related tax benefits					343
Share-based compensation					499
Tax withholdings related to vesting of share-based payments					(196)
Dividends	(857)	$ (862)	$ (798)	$ (801)	(1,719)	(1,599)
Stock repurchases					(425)	$ (727)
Balance at end of the period	$ 23,819				$ 23,819

Stockholders' Equity Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			$ 384
Balance at end of period	$ 545		545
Investment and other income, net	96	$ 235	211	$ 417
Foreign Currency Translation Adjustment [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			147
Other comprehensive income (loss) before reclassifications			173
Reclassifications from accumulated other comprehensive income			0
Other comprehensive income (loss)			173
Balance at end of period	320		320
Noncredit Other-than-Temporary Impairment Losses and Subsequent Changes in Fair Value for Certain Available-for-Sale Debt Securities [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			23
Other comprehensive income (loss) before reclassifications			0
Reclassifications from accumulated other comprehensive income			1
Other comprehensive income (loss)			1
Balance at end of period	24		24
Net Unrealized Gain (Loss) on Other Available-for-Sale Securities [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			218
Other comprehensive income (loss) before reclassifications			(1)
Reclassifications from accumulated other comprehensive income			(9)
Other comprehensive income (loss)			(10)
Balance at end of period	208		208
Net Unrealized (Loss) Gain on Derivative Instruments [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			(8)
Other comprehensive income (loss) before reclassifications			(6)
Reclassifications from accumulated other comprehensive income			3
Other comprehensive income (loss)			(3)
Balance at end of period	(11)		(11)
Other Gains [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			4
Other comprehensive income (loss) before reclassifications			0
Reclassifications from accumulated other comprehensive income			0
Other comprehensive income (loss)			0
Balance at end of period	4		4
Total Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Balance at beginning of period			384
Other comprehensive income (loss) before reclassifications			166
Reclassifications from accumulated other comprehensive income			(5)
Other comprehensive income (loss)			161
Balance at end of period	$ 545		$ 545
Reclassification out of Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income Attributable to Parent, Net of Tax [Roll Forward]
Investment and other income, net		$ 35		$ 48

Stockholders' Equity Share Repurchase Program (Details) - USD ($) shares in Millions, $ in Millions	6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 09, 2015
Equity, Class of Treasury Stock [Line Items]
Authorized amount			$ 15,000
Stock repurchased and retired during period, shares	6.8	11.5
Stock repurchased and retired during period, value	$ 425	$ 727
Remaining authorized amount	$ 1,200

Stockholders' Equity Dividends (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	2 Months Ended	3 Months Ended				6 Months Ended
	Jun. 20, 2018	Apr. 17, 2018	May 30, 2018	Mar. 25, 2018	Dec. 24, 2017	Mar. 26, 2017	Dec. 25, 2016	Mar. 25, 2018	Mar. 26, 2017	Mar. 08, 2018
Dividends [Line Items]
Percentage increase common stock dividend per share announced										9.00%
Dividends per share announced				$ 0.57	$ 0.57	$ 0.53	$ 0.53	$ 1.14	$ 1.06
Dividends				$ 857	$ 862	$ 798	$ 801	$ 1,719	$ 1,599
Amount of increased common stock dividends per share announced										$ 0.62
Subsequent Event [Member]
Dividends [Line Items]
Dividends per share announced		$ 0.62
Dividends payable, date declared		Apr. 17, 2018
Dividends payable, date to be paid	Jun. 20, 2018
Dividends payable, date of record			May 30, 2018

Stockholders' Equity Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plans [Member] - shares	Mar. 23, 2018	Mar. 25, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Increase in authorized shares	30,000,000
Shares authorized		101,709,000

Credit Facilities (Details) - USD ($) $ in Millions	3 Months Ended	6 Months Ended	12 Months Ended
Credit Facilities (Details) - USD ($) $ in Millions	Mar. 25, 2018	Mar. 25, 2018	Sep. 24, 2017
2016 Amended Revolving Credit Facility [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	$ 5,000	$ 5,000
Line of Credit Facility, Covenant Terms		maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in each of the respective agreements, of not less than three to one at the end of each fiscal quarter
Line of Credit Facility, Covenant Compliance		the Company was in compliance with the applicable covenants
2016 Amended Revolving Credit Facility [Member] \| February 2020 [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	530	$ 530
Credit Facility, Expiration Date		Feb. 18, 2020
2016 Amended Revolving Credit Facility [Member] \| November 2021 [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	4,470	$ 4,470
Credit Facility, Expiration Date		Nov. 08, 2021
2018 Revolving Credit Facility [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	$ 3,000	$ 3,000
Line of Credit Facility, Description	Commitments under the 2018 Revolving Credit Facility will expire on the first to occur of (i) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP, (ii) if the closing date under the 2018 Revolving Credit Facility has not occurred, the date that is five business days following July 25, 2018 and (iii) the termination of the commitments in accordance with the provisions of the 2018 Revolving Credit Facility providing for voluntary and mandatory commitment reductions.
Line of Credit Facility, Interest Rate Description	Loans under the 2018 Revolving Credit Facility will mature on December 31, 2018 and will bear interest, at the option of the Company, at either the reserve-adjusted Eurocurrency Rate (determined in accordance with the 2018 Revolving Credit Facility) or the Base Rate (determined in accordance with the 2018 Revolving Credit Facility), in each case plus an applicable margin based on the Company’s long-term unsecured senior, non-credit enhanced debt ratings. The initial margins over the reserve-adjusted Eurocurrency Rate and the Base Rate based on Qualcomm’s debt ratings as of March 25, 2018 will be 0.75% and 0.00% per annum, respectively.
Debt instrument, ticking fee	The 2018 Revolving Credit Facility has a ticking fee, which is based on Qualcomm’s debt ratings and initially accrues at a rate of 0.05% per annum
Line of Credit Facility, Covenant Terms	maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in each of the respective agreements, of not less than three to one at the end of each fiscal quarter
Line of Credit Facility, Covenant Compliance	the Company was in compliance with the applicable covenants
Commercial Paper [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	$ 5,000	5,000
Outstanding Commercial Paper Classified as Short-term debt	$ 2,200	$ 2,200	$ 999
Commercial Paper, Weighted Average Interest Rate	1.98%	1.98%	1.19%
Commercial Paper [Member] \| Minimum [Member]
Line of Credit Facility [Abstract]
Debt Instrument, Term		1 day
Commercial Paper [Member] \| Maximum [Member]
Line of Credit Facility [Abstract]
Debt Instrument, Term		397 days
Commercial Paper [Member] \| Weighted Average [Member]
Line of Credit Facility [Abstract]
Commercial Paper, Weighted Average Remaining Term		44 days	45 days
2016 Term Loan Facility [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	$ 4,000	$ 4,000
Line of Credit Facility, Description		will expire on the first to occur of (i) the consummation of the proposed acquisition of NXP without using loans under the 2016 Term Loan Facility, (ii) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP and (iii) the date that is five business days following July 25, 2018.
Line of Credit Facility, Covenant Terms		maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in each of the respective agreements, of not less than three to one at the end of each fiscal quarter
Line of Credit Facility, Covenant Compliance		the Company was in compliance with the applicable covenants
2018 Term Loan Facility [Member]
Line of Credit Facility [Abstract]
Credit Facility, Maximum Borrowing Capacity	$ 3,000	$ 3,000
Line of Credit Facility, Description	Commitments under the 2018 Term Loan Facility will expire on the first to occur of (i) the consummation of the proposed acquisition of NXP without using loans under the 2018 Term Loan Facility, (ii) the termination of Qualcomm River Holdings’s obligation to consummate the proposed acquisition of NXP, (iii) the date that is five business days following July 25, 2018 and (iv) the termination of the commitments in accordance with the provisions of the 2018 Term Loan Facility providing for voluntary and mandatory commitment reductions.
Line of Credit Facility, Interest Rate Description	Loans under the 2018 Term Loan Facility will mature on December 31, 2018 and will bear interest, at the option of the Company, at either the reserve-adjusted Eurocurrency Rate (determined in accordance with the 2018 Term Loan Facility) or the Base Rate (determined in accordance with the 2018 Term Loan Facility), in each case plus an applicable margin based on the Company’s long-term unsecured senior, non-credit enhanced debt ratings. The initial margins over the reserve-adjusted Eurocurrency Rate and the Base Rate based on Qualcomm’s debt ratings as of March 25, 2018 will be 0.875% and 0.00% per annum, respectively.
Debt instrument, ticking fee	The 2018 Term Loan Facility has a ticking fee, which is based on Qualcomm’s debt ratings and initially accrues at a rate of 0.05% per annum
Line of Credit Facility, Covenant Terms	maintain a ratio of consolidated earnings before interest, taxes, depreciation and amortization to consolidated interest expense, as defined in each of the respective agreements, of not less than three to one at the end of each fiscal quarter
Line of Credit Facility, Covenant Compliance	the Company was in compliance with the applicable covenants

Debt Long-term Debt (Details) - USD ($) $ in Millions	6 Months Ended		12 Months Ended
Debt Long-term Debt (Details) - USD ($) $ in Millions	Mar. 25, 2018	Mar. 26, 2017	Sep. 24, 2017
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 21,000		$ 21,000
Unamortized discount including debt issuance costs, Net	(97)		(106)
Hedge accounting fair value adjustments	(43)		0
Interest paid related to commercial paper and long-term debt, net of cash received from the related interest rate swaps	317	$ 150
Debt, long-term and short-term, combined amount	20,860		20,894
Long-term debt, current maturities	1,499		1,496
Long-term debt	$ 19,361		19,398
Special mandatory redemption description, aggregate principal amount and redemption price	The Company’s 2019 floating-rate notes, 2020 floating-rate notes, 2019 fixed-rate notes and 2020 fixed-rate notes issued in May 2017 for an aggregate principal amount of $4.0 billion are subject to a special mandatory redemption at a price equal to 101% of the aggregate principal amount, plus accrued and unpaid interest to, but excluding, the date of such mandatory redemption.
Special mandatory redemption description of terms and dates	The redemption is required on the first to occur of (i) the termination of the NXP purchase agreement or (ii) if the NXP transaction has not closed, by June 1, 2018.
Long-term debt, fair value	$ 20,500		21,500
Floating-rate three-month LIBOR plus 0.27% notes due May 18, 2018 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 250		$ 250
Long-term debt, effective interest rate	2.21%		1.65%
Long-term debt, maturity date	May 18, 2018		May 18, 2018
Long-term debt, basis spread on variable rate	0.27%		0.27%
Long-term debt, interest rate terms	Variable per annum rate equal to three-month LIBOR as determined on the interest determination date plus 0.27%.
Floating-rate three-month LIBOR plus 0.55% notes due May 20, 2020 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 250		$ 250
Long-term debt, effective interest rate	2.49%		1.92%
Long-term debt, maturity date	May 20, 2020		May 20, 2020
Long-term debt, basis spread on variable rate	0.55%		0.55%
Long-term debt, interest rate terms	Variable per annum rate equal to three-month LIBOR as determined on the interest determination date plus 0.55%.
Fixed-rate 1.40% notes due May 18, 2018 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,250		$ 1,250
Long-term debt, effective interest rate	2.94%		1.93%
Long-term debt, stated interest rate	1.40%		1.40%
Long-term debt, maturity date	May 18, 2018		May 18, 2018
Fixed-rate 2.25% notes due May 20, 2020 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,750		$ 1,750
Long-term debt, effective interest rate	2.79%		2.20%
Long-term debt, stated interest rate	2.25%		2.25%
Long-term debt, maturity date	May 20, 2020		May 20, 2020
Percentage of debt hedged by interest rate derivatives	43.00%
Fixed-rate 3.00% notes due May 20, 2022 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 2,000		$ 2,000
Long-term debt, effective interest rate	3.34%		2.65%
Long-term debt, stated interest rate	3.00%		3.00%
Long-term debt, maturity date	May 20, 2022		May 20, 2022
Percentage of debt hedged by interest rate derivatives	50.00%
Fixed-rate 3.45% notes due May 20, 2025 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 2,000		$ 2,000
Long-term debt, effective interest rate	3.46%		3.46%
Long-term debt, stated interest rate	3.45%		3.45%
Long-term debt, maturity date	May 20, 2025		May 20, 2025
Fixed-rate 4.65% notes due May 20, 2035 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,000		$ 1,000
Long-term debt, effective interest rate	4.74%		4.74%
Long-term debt, stated interest rate	4.65%		4.65%
Long-term debt, maturity date	May 20, 2035		May 20, 2035
Fixed-rate 4.80% notes due May 20, 2045 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,500		$ 1,500
Long-term debt, effective interest rate	4.71%		4.71%
Long-term debt, stated interest rate	4.80%		4.80%
Long-term debt, maturity date	May 20, 2045		May 20, 2045
Floating-rate three-month LIBOR plus 0.36% notes due May 20, 2019 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 750		$ 750
Long-term debt, effective interest rate	2.37%		1.80%
Long-term debt, maturity date	May 20, 2019		May 20, 2019
Long-term debt, basis spread on variable rate	0.36%		0.36%
Long-term debt, interest rate terms	Variable per annum rate equal to three-month LIBOR as determined on the interest determination date plus 0.36%.
Floating-rate three-month LIBOR plus 0.45% notes due May 20, 2020 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 500		$ 500
Long-term debt, effective interest rate	2.43%		1.86%
Long-term debt, maturity date	May 20, 2020		May 20, 2020
Long-term debt, basis spread on variable rate	0.45%		0.45%
Long-term debt, interest rate terms	Variable per annum rate equal to three-month LIBOR as determined on the interest determination date plus 0.45%.
Floating-rate three-month LIBOR plus 0.73% notes due January 30, 2023 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 500		$ 500
Long-term debt, effective interest rate	2.56%		2.11%
Long-term debt, maturity date	Jan. 30, 2023		Jan. 30, 2023
Long-term debt, basis spread on variable rate	0.73%		0.73%
Long-term debt, interest rate terms	Variable per annum rate equal to three-month LIBOR as determined on the interest determination date plus 0.73%.
Fixed-rate 1.85% notes due May 20, 2019 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,250		$ 1,250
Long-term debt, effective interest rate	2.00%		2.00%
Long-term debt, stated interest rate	1.85%		1.85%
Long-term debt, maturity date	May 20, 2019		May 20, 2019
Fixed-rate 2.10% notes due May 20, 2020 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,500		$ 1,500
Long-term debt, effective interest rate	2.19%		2.19%
Long-term debt, stated interest rate	2.10%		2.10%
Long-term debt, maturity date	May 20, 2020		May 20, 2020
Fixed-rate 2.60% notes due January 30, 2023 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,500		$ 1,500
Long-term debt, effective interest rate	2.70%		2.70%
Long-term debt, stated interest rate	2.60%		2.60%
Long-term debt, maturity date	Jan. 30, 2023		Jan. 30, 2023
Fixed-rate 2.90% notes due May 20, 2024 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,500		$ 1,500
Long-term debt, effective interest rate	3.01%		3.01%
Long-term debt, stated interest rate	2.90%		2.90%
Long-term debt, maturity date	May 20, 2024		May 20, 2024
Fixed-rate 3.25% notes due May 20, 2027 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 2,000		$ 2,000
Long-term debt, effective interest rate	3.46%		3.46%
Long-term debt, stated interest rate	3.25%		3.25%
Long-term debt, maturity date	May 20, 2027		May 20, 2027
Fixed-rate 4.30% notes due May 20, 2047 [Member]
Long-term Debt [Abstract]
Long-term debt, principal amount	$ 1,500		$ 1,500
Long-term debt, effective interest rate	4.47%		4.47%
Long-term debt, stated interest rate	4.30%		4.30%
Long-term debt, maturity date	May 20, 2047		May 20, 2047
Interest Rate Swap [Member]
Long-term Debt [Abstract]
Gross notional amount of derivatives	$ 3,000

Commitments and Contingencies Legal and Regulatory Proceedings (Details) € in Millions, $ in Millions, ₩ in Billions, $ in Billions	3 Months Ended		6 Months Ended			12 Months Ended			59 Months Ended
	Dec. 24, 2017 USD ($)	Sep. 24, 2017 USD ($)	Mar. 25, 2018 USD ($)	Mar. 25, 2018 EUR (€)	Mar. 26, 2017 USD ($)	Sep. 24, 2017 KRW (₩)	Sep. 24, 2017 USD ($)	Sep. 24, 2017 TWD ($)	Dec. 31, 2022
KFTC [Member]
Loss Contingencies [Line Items]
Loss contingency, loss in period					$ 921		$ 927
KFTC [Member] \| Korea (South), Won
Loss Contingencies [Line Items]
Loss contingency, loss in period \| ₩						₩ 1,030
EC [Member]
Loss Contingencies [Line Items]
Loss contingency, loss in period	$ 1,180		$ 1,180
Loss contingency, accrual, current		$ 0	1,232				0
EC [Member] \| Euro Member Countries, Euro
Loss Contingencies [Line Items]
Loss contingency, loss in period \| €				€ 997
TFTC [Member]
Loss Contingencies [Line Items]
Loss contingency, loss in period		778
Loss contingency, total accrual			771
Loss contingency, accrual, current		$ 778	156				$ 778
Loss contingency, accrual, noncurrent			$ 615
TFTC [Member] \| Taiwan, New Dollars
Loss Contingencies [Line Items]
Loss contingency, loss in period								$ 23.4
Scenario, Forecast [Member] \| TFTC [Member]
Loss Contingencies [Line Items]
Loss contingency, payment terms									paid in monthly installments through December 2022.

Commitments and Contingencies Purchase Obligations (Details) $ in Millions	6 Months Ended
	Mar. 25, 2018 USD ($)
Unrecorded Unconditional Purchase Obligation [Line Items]
Description of lessee leasing arrangements, operating leases	The Company leases certain of its land, facilities and equipment under noncancelable operating leases, with terms ranging from less than one year to 21 years and with provisions in certain leases for cost-of-living increases.
Remainder of fiscal 2018 - Unrecorded obligation	$ 894
Fiscal 2019 - Unrecorded obligations	286
Fiscal 2020 - Unrecorded obligations	165
Fiscal 2021 - Unrecorded obligations	60
Fiscal 2022 - Unrecorded obligations	12
Thereafter - Unrecorded obligations	4
Total - Unrecorded obligations	1,421
Inventories [Member]
Unrecorded Unconditional Purchase Obligation [Line Items]
Remainder of fiscal 2018 - Unrecorded obligation	2,277
Fiscal 2019 - Unrecorded obligations	1,074
Fiscal 2020 - Unrecorded obligations	318
Fiscal 2021 - Unrecorded obligations	63
Fiscal 2022 - Unrecorded obligations	24
Thereafter - Unrecorded obligations	0
Total - Unrecorded obligations	$ 3,756

Commitments and Contingencies Operating Leases (Details) $ in Millions	6 Months Ended
	Mar. 25, 2018 USD ($)
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Description of lessee leasing arrangements, operating leases	The Company leases certain of its land, facilities and equipment under noncancelable operating leases, with terms ranging from less than one year to 21 years and with provisions in certain leases for cost-of-living increases.
Remainder of fiscal 2018 - Operating Lease	$ 63
Fiscal 2019 - Operating leases	114
Fiscal 2020 - Operating leases	85
Fiscal 2021 - Operating leases	64
Fiscal 2022 - Operating leases	44
Thereafter - Operating leases	57
Total Operating Leases Payments Due	$ 427

Commitments and Contingencies Other Commitments (Details) $ in Millions	Mar. 25, 2018 USD ($)
QSI [Member]
Other Commitments [Line Items]
Other Commitments	$ 414
Remainder of fiscal 2018 - Other Commitments	77
Other Commitment, due in fiscal 2021	72
Minimum [Member] \| QCT [Member]
Other Commitments [Line Items]
Other Commitments	90
Maximum [Member] \| QCT [Member]
Other Commitments [Line Items]
Other Commitments	$ 315

Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Segment Information (Details) - USD ($) $ in Millions	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017	Sep. 24, 2017
Segment Reporting Information [Line Items]
Segment reporting, factors used to identify entity's reportable segments			The Company is organized on the basis of products and services and has three reportable segments.
Revenues	$ 5,261	$ 5,016	$ 11,329	$ 11,015
Earnings before taxes	358	857	332	1,727
Total assets	64,126		64,126		$ 65,486
Cost of revenues	(2,239)	(2,208)	(4,902)	(4,651)
Research and development expense	(1,402)	(1,386)	(2,822)	(2,697)
Selling, general and administrative expense	(869)	(615)	(1,641)	(1,206)
Other expenses	(310)	(78)	(1,493)	(954)
Interest expense	(179)	(107)	(350)	(197)
Investment and other income, net	96	235	211	417
QCT [Member]
Segment Reporting Information [Line Items]
Revenues	3,897	3,676	8,548	7,777
Earnings before taxes	608	475	1,563	1,199
Total assets	3,336		3,336		3,830
QTL [Member]
Segment Reporting Information [Line Items]
Revenues	1,260	2,249	2,559	4,060
Earnings before taxes	850	1,959	1,738	3,492
Total assets	1,907		1,907		1,735
QSI [Member]
Segment Reporting Information [Line Items]
Revenues	30	0	60	14
Earnings before taxes	40	0	51	(17)
Total assets	1,193		1,193		1,037
Other Segments [Member]
Segment Reporting Information [Line Items]
Revenues	74	65	162	138
Earnings before taxes	(93)	(108)	(186)	(189)
Reconciling Items [Member]
Segment Reporting Information [Line Items]
Revenues	74	(909)	162	(836)
Earnings before taxes	(1,140)	(1,577)	(3,020)	(2,947)
Total assets	57,690		57,690		$ 58,884
Cost of revenues	(111)	(119)	(228)	(213)
Research and development expense	(271)	(277)	(551)	(546)
Selling, general and administrative expense	(258)	(138)	(420)	(283)
Other expenses	(310)	(78)	(1,493)	(954)
Interest expense	(179)	(106)	(348)	(195)
Investment and other income, net	82	223	$ 206	407
Reconciling Items [Member] \| Corporate, Non-Segment [Member]
Segment Reporting Information [Line Items]
Segment reporting, change in measurement methods			In fiscal 2018, all of the costs related to pre-commercial research and development of 5G (fifth generation) technology, of which $115 million and $216 million was recorded in the three and six months ended March 25, 2018, respectively, are included in unallocated corporate research and development expenses, whereas similar costs related to the research and development of other technology, including 3G (third generation) and 4G (fourth generation) technology, were recorded in both the QCT and QTL segments.
Reconciling Items [Member] \| Change of Segment Methodology [Member]
Segment Reporting Information [Line Items]
Research and development expense	(115)		$ (216)
Cost of revenues [Member] \| Reconciling Items [Member]
Segment Reporting Information [Line Items]
Unallocated acquisition-related expenses	102	106	208	191
Research and development expenses [Member] \| Reconciling Items [Member]
Segment Reporting Information [Line Items]
Unallocated acquisition-related expenses	2	12	3	14
Selling, general and administrative expenses [Member] \| Reconciling Items [Member]
Segment Reporting Information [Line Items]
Unallocated acquisition-related expenses	214	57	290	118
Blackberry [Member] \| Reconciling Items [Member]
Segment Reporting Information [Line Items]
Revenues	$ 0	$ (974)	$ 0	$ (974)

Acquisitions (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 24, 2018	Mar. 25, 2018	Mar. 25, 2018	Feb. 20, 2018	Feb. 19, 2018	Sep. 24, 2017
Business Acquisition [Line Items]
Long-term debt, principal amount		$ 21,000	$ 21,000			$ 21,000
Goodwill		6,676	$ 6,676			$ 6,623
NXP [Member]
Business Acquisition [Line Items]
Business Acquisition, Date of Acquisition Agreement			Oct. 27, 2016
Business acquisition, share price					$ 110.00
Business Combination, Termination Fee, Specified Circumstances, Payable to Acquirer			$ 1,250
Business Combination, Termination Fee, Specified Circumstances, Payable to Target			2,000
Letters of Credit Outstanding, Amount		$ 2,000	2,000
Amendment No.1 NXP Purchase Agreement [Member]
Business Acquisition [Line Items]
Business Acquisition, Date of Acquisition Agreement		Feb. 20, 2018
Cash consideration		$ 44,000
Business acquisition, share price				$ 127.50
Subsequent Event [Member] \| Amendment No. 2 NXP Purchase Agreement [Member]
Business Acquisition [Line Items]
Business Acquisition, Date of Acquisition Agreement	Apr. 19, 2018
Minimum [Member] \| NXP [Member]
Business Acquisition [Line Items]
Business acquisition, percentage of voting interested acquired					80.00%
Minimum [Member] \| Amendment No.1 NXP Purchase Agreement [Member]
Business Acquisition [Line Items]
Business acquisition, percentage of voting interested acquired				70.00%
2016 Term Loan Facility [Member]
Business Acquisition [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		4,000	4,000
2018 Term Loan Facility [Member]
Business Acquisition [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		3,000	3,000
2018 Revolving Credit Facility [Member]
Business Acquisition [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		3,000	3,000
May 2017 debt issuance [Member]
Business Acquisition [Line Items]
Long-term debt, principal amount		$ 11,000	$ 11,000

Cost Plan (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended	12 Months Ended	20 Months Ended
Cost Plan (Details) - USD ($) $ in Millions	Mar. 25, 2018	Mar. 26, 2017	Mar. 26, 2017	Sep. 29, 2019	Sep. 29, 2019
Restructuring Cost and Reserve [Line Items]
Cost Reduction Plan, announcement date	Jan. 16, 2018
Reduction of annual costs	$ 1,000
Restructuring and restructuring-related charges	310	$ 25	$ 33
Other Operating Income (Expense) [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	277
Other Restructuring Costs	$ 33
Scenario, Forecast [Member]
Restructuring Cost and Reserve [Line Items]
Cost Reduction Plan, completion date				Sep. 29, 2019
Scenario, Forecast [Member] \| Minimum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and restructuring-related charges					$ 400
Scenario, Forecast [Member] \| Maximum [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and restructuring-related charges					$ 525

Fair Value Measurements Fair Value Hierarchy (Details) - Fair Value, Measurements, Recurring [Member] $ in Millions	Mar. 25, 2018 USD ($)
Assets
Cash equivalents	$ 36,901
Marketable securities	1,658
Derivative instruments	7
Other investments	421
Total assets measured at fair value	38,987
Liabilities
Derivative instruments	65
Other liabilities	602
Total liabilities measured at fair value	667
Level 1 [Member]
Assets
Cash equivalents	26,328
Marketable securities	50
Derivative instruments	0
Other investments	408
Total assets measured at fair value	26,786
Liabilities
Derivative instruments	0
Other liabilities	408
Total liabilities measured at fair value	408
Level 2 [Member]
Assets
Cash equivalents	10,573
Marketable securities	1,573
Derivative instruments	7
Other investments	0
Total assets measured at fair value	12,153
Liabilities
Derivative instruments	65
Other liabilities	0
Total liabilities measured at fair value	65
Level 3 [Member]
Assets
Cash equivalents	0
Marketable securities	35
Derivative instruments	0
Other investments	13
Total assets measured at fair value	48
Liabilities
Derivative instruments	0
Other liabilities	194
Total liabilities measured at fair value	194
U.S. Treasury securities and government-related securities [Member]
Assets
Marketable securities	12
U.S. Treasury securities and government-related securities [Member] \| Level 1 [Member]
Assets
Marketable securities	10
U.S. Treasury securities and government-related securities [Member] \| Level 2 [Member]
Assets
Marketable securities	2
U.S. Treasury securities and government-related securities [Member] \| Level 3 [Member]
Assets
Marketable securities	0
Corporate bonds and notes [Member]
Assets
Marketable securities	1,498
Corporate bonds and notes [Member] \| Level 1 [Member]
Assets
Marketable securities	0
Corporate bonds and notes [Member] \| Level 2 [Member]
Assets
Marketable securities	1,498
Corporate bonds and notes [Member] \| Level 3 [Member]
Assets
Marketable securities	0
Mortgage- and asset-backed and auction rate securities [Member]
Assets
Marketable securities	108
Mortgage- and asset-backed and auction rate securities [Member] \| Level 1 [Member]
Assets
Marketable securities	0
Mortgage- and asset-backed and auction rate securities [Member] \| Level 2 [Member]
Assets
Marketable securities	73
Mortgage- and asset-backed and auction rate securities [Member] \| Level 3 [Member]
Assets
Marketable securities	35
Equity and preferred securities and equity funds [Member]
Assets
Marketable securities	40
Equity and preferred securities and equity funds [Member] \| Level 1 [Member]
Assets
Marketable securities	40
Equity and preferred securities and equity funds [Member] \| Level 2 [Member]
Assets
Marketable securities	0
Equity and preferred securities and equity funds [Member] \| Level 3 [Member]
Assets
Marketable securities	$ 0

Marketable Securities (Details) - USD ($) $ in Millions	Mar. 25, 2018	Sep. 24, 2017
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	$ 1,623	$ 2,275
Available-for-sale - Noncurrent	35	1,270
Total marketable securities - Current	1,625	2,279
Total marketable securities - Noncurrent	35	1,270
U.S. Treasury securities and government-related securities [Member]
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	12	23
Available-for-sale - Noncurrent	0	959
Corporate bonds and notes [Member]
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	1,498	2,014
Available-for-sale - Noncurrent	0	271
Mortgage- and asset-backed and auction rate securities [Member]
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	73	93
Available-for-sale - Noncurrent	35	40
Equity and preferred securities and equity funds [Member]
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	40	36
Available-for-sale - Noncurrent	0	0
Debt funds [Member]
Schedule of Marketable Securities [Line Items]
Available-for-sale - Current	0	109
Available-for-sale - Noncurrent	0	0
Bank Time Deposits [Member]
Schedule of Marketable Securities [Line Items]
Other Marketable Securities, Current	2	4
Other Marketable Securities, Noncurrent	$ 0	$ 0

Marketable Securities Available-for-sale Securities (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 25, 2018	Mar. 26, 2017	Mar. 25, 2018	Mar. 26, 2017	Sep. 24, 2017
Contractual maturities of available-for-sale debt securities [Abstract]
Years to Maturity - Less Than One Year	$ 610		$ 610
Years to Maturity - One to Five Years	900		900
Years to Maturity - Five to Ten Years	0		0
Years to Maturity - Greater Than Ten Years	0		0
Years to Maturity - No Single Maturity Date	108		108
Realized Gains and Losses on Sales of Available-for-sale Securities [Abstract]
Gross Realized Gains	11	$ 57	13	$ 303
Gross Realized Losses	0	0	0	(107)
Net Realized Gains	11	$ 57	13	$ 196
Available-for-sale Securities [Abstract]
Available-for-sale Equity Securities, Cost	8		8		$ 8
Available-for-sale Equity Securities, Unrealized Gains	32		32		28
Available-for-sale Securities Equity Securities, Fair Value	40		40		36
Available-for-sale Debt Securities (including debt funds), Cost	1,621		1,621		3,497
Available-for-sale Debt Securities (including debt funds), Unrealized Gains	3		3		13
Available-for-sale Debt Securities (including debt funds), Unrealized Losses	(6)		(6)		(1)
Available-for-sale Debt Securities, Fair Value	1,618		1,618		3,509
Fair Value	$ 1,658		$ 1,658		$ 3,545